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Abbreviations 
CD, circular dichroism. 
DPI, des-(B26-B30) pentapeptide human insulin. 
DQF-COSY, double quantum filtered two-dimensional correlated spectroscopy. 
FID, free induction decay. 
HI, human insulin. 
HMQC, hetero-nuclear multiple-quantum coherence. 
NMR, nuclear magnetic resonance. 
NOE, nuclear Overhauser enhancement. 
NOESY, two-dimensional nuclear Overhauser enhanced spectroscopy. 
TOCSY, two-dimensional total correlation spectroscopy. 
rms, root mean square. 
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1. Introduction 
The insulin dependent diabetes mellitus (IDDM) is characterized by a reduced or completely absent 
production of endogenous insulin. Patients suffering from this chronic disease are treated with daily 
subcutaneous injections of insulin preparations to keep their blood glucose level under control. The efficiency of 
this insulin therapy to imitate a normal insulin level in the blood is of vital importance to the diabetics in 
ensuring their daily health and suppressing the development of late complications. At Novo Nordisk A/S 
ongoing research aims at optimizing this therapy as to mimick the ‘normal’ timing and profile of insulin in the 
blood. 
An attractive longterm goal is, however, to replace the injection therapy by insulin-mimetica to be 
administered peroral. Thus, in recent years much effort has been put into characterizing the insulin-binding 
regions of the insulin receptor and into elucidating the relationship between the spatial structure of the insulin 
molecule and its affinity for the insulin receptor. The three dimensional structure of insulin in the hexameric 
units of insulin crystals has been intensively investigated by X-ray crystallography during the recent decades 
(Adams et al., 1969, Smith et al., 1984, Derewenda et al., 1989), whereas the structure of the insulin receptor 
with or without insulin bound is unknown. Until now, structural determinations of insulin species in aqueous 
solution by NMR spectroscopy of the biological active form of the molecule, the monomer, has been conducted 
at acidic pH or in the presence of organic co-solvents (Knegtel et al.; 1991, Hua et al., 1991, 1992a, 1993b; 
Ludvigsen et al., 1994; Jorgensen et al., 1996). A prerequisite for detailed investigations of the 
structure/receptor affmity relationship of insulin is to determine the three dimensional structure of the 
monomeric insulin species in aqueous solution at physiological pH. Despite its small size (51 amino acids, 
5808 Dalton) a complicated pattern of aggregation and precipitation properties of insulin hampers the 
structural investigations of the native species in the neutral pH range. Recently, the access to genetical 
engineering has facilitated the production of insulin species with mutations of specific residues and it has 
proved possible to manipulate the aggregation properties and the biological activity independently. 
The introduction of two dimensional ‘H experiments in the early 80’s enabled the use of NMR for 
determination of the three dimensional structure of proteins in solution. Using the information from a series of 
2D experiments it became possible to assign the spectra of proteins (up to approximately 100 residues) and to 
extract the information about inter-proton distances from NOES that is the input to structure calculations. The 
development of 3D and 4D experiments correlating protons with “N and 13C nuclei together with the ability to 
enrich the proteins with these NMR active isotopes of nitrogen and carbon pushed the limits to even larger 
proteins (up to approximately 300 residues). The “N and 13C enrichments also opened the possibility to 
investigate the dynamics of the backbone and the sidechains on the picosecond-nanoseconds timescale. 
Compared to structure determination in crystals by X-ray crystallography the NMR method is still more time- 
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consuming and outnumbered, however the information concerning the dynamics on different time scales that is 
obtainable horn the NMR data is extremely valuable and not available from X-ray crystallography. 
The work presented in this thesis is centered on the determination of the three dimensional structure of 
a biological active mutant of human insulin at neutral pH by NMR spectroscopy. The backbone dynamics of 
this mutant and of a mutant of which the structure is known at acidic pH are examined and compared. Finally 
the sequential assignment and secondary structural elements of a pair of insulin mutants \\ith manipulated 
biological activity is presented. 
Chapter 2 of this thesis describes the determination by NMR of the three dimensional structure of the 
(Bl, BlO, B16, B27) Glu, des-B30 mutant of human insulin in aqueous solution at pH 6.5. The mutant is 
monomeric in the neutral pH range at the millimolar concentration needed for structural investigations by 
NMR. The biological activity of the mutant is 47 % of that of the native species. The work has been submitted 
for publication in Biochemistry in the form enclosed in Appendix A. Besides the addition of the Figures 2.1 
and 2.2 in Chapter 2 and insertion of Figure 4 of the appendix into Figure 2.6 in Chapter 2 the contents of 
Chapter 2 and Appendix A are identical. 
Chapter 3 presents the examination of the backbone dynamics of the (Bl, BlO, B16. B27) Glu, des- 
B30 mutant and the B16 His des-B30 mutant of which the structure has been published at acidic pH (Ludvigsen 
et al., 1994). Using samples uniformly enriched with the NMR active isotope of Nitrogen,“N. the relaxation 
parameters of the backbone “N nuclei are determined and translated to a generalized order parameter. This 
order parameter describes the spatial restriction of the picosecond-nanosecond motions of the ‘N’H-vector of ., 
each residue. Millisecond timescale dynamics are evaluated as well. The contents of this Chapter is under 
preparation for publication. 
Chapter 4 describes the preliminary structural investigations of two insulin mutants with manipulated 
biological activity achieved by point mutations of the (Bl, BIO, B16, B27) Glu, des-B30 mutant. Both mutants 
are monomeric in the millimolar range and at neutral pH. The biological activity of the A3 Gly (Bl, BlO, B16, 
B27) Glu, des-B30 mutant is reduced to 0.1 % compared to the native species whereas that of the AS His (Bl, 
BlO, B16, B27) Glu, des-B30 mutant is increased to 143%. 
The efforts of engineering, expressing , fermenting and purifying the insulin mutants. were completed 
before the initiation of my work. My contributions have been to record and assign the spectra as well as to 
calculate the three dimensional structure of the (Bl, BlO, B16, B27) Glu, des B30 mutant. Furthermore the 
extraction of “N relaxation parameters and development of the software necessary to translate these to the 
parameters describing the backbone dynamics is my work as well. In parallel to the work described in the 
present thesis, I have been involved in the development of new heteronuclear pulse-sequences as published in 
Olsen et al., lYY3a,b. in the same period. 
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2. Structure of an Engineered Insulin Monomer at Neutral pH 
2.1 Abstract 
lnsulin circulates in the bloodstream and binds to its specific cell-surface receptor as a 5808 Dalton 
monomeric species. However, studies of the monomer structure and dynamics in solution are severely limited by 
insulin self-association into dimers and higher oligomers. In the present work we use site-directed mutagenesis of the 
dimer- and hexamer-forming surfaces to yield the first insulin species amenable for structure determination at neutral 
pH by nuclear magnetic resonance @MR) spectroscopy. The preferred insulin mutant, i.e., (Bl, BlO, B16, B27) Glu, 
des-B30 insulin retains 47% biological potency, and remains monomeric at millimolar concentrations in aqueous 
solution at pH 6.5-7.5 as judged by NMR and near-UV circular dichroism (CD) spectroscopy. From a series of 2D ‘H- 
NMR spectra collected at pH 6.5 and 34”C, the majority of the resonances are assigned to specific residues in the 
sequence, and nuclear Overhauser enhancement (NOE) cross-peaks are identified. NOE-derived distance restraints in 
conjunction with torsion restraints based on measured coupling constants, 3JnNn”, are used for structure calculations 
using the hybrid method of distance geometry and simulated annealing. The calculated structures show that the major 
part of the insulin mutant is structurally well-defined with an average root mean square (rms) deviation between the 
25 calculated structures and the mean coordinates of 0.66 8, for backbone atoms (A2-Al9 and B4-B26) and 1.3 1 A for 
all backbone atoms. The A-chain consists of two antiparallel helices, A2-A7 and A12-A19, connected by a loop. The 
B-chain contains a loop region (Bl-BS), an a-helix (B9-B19), a Qpe I turn (l320-B23), and terminates as an extended 
strand (B24-B29). The Bl-B4 and B27-B29 regions are disorded in solution. The structure is generally similar to 
crystal structures and resembles a crystalline T-state more than an R-state in the sense that the B-chain helix is 
confined to residues B9-B 19. 
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Figure 2.1 The primary structure of human insulin. Layout adapted from Brange et al., (1990). The lines 
indicate disulfide bridges. The colored residues are located in the aggregation surfaces. Green residues are 
involved in dimer formation, and blue residues are involved in the assembly of dimers into hexamers. 
2.2 Introduction 
insulin is central to the hormonal control of 
metabolism. Due to its importance as a pharma- 
ceutical preparation for the treatment of diabetes 
mellitus, much effort has been directed towards 
understanding the structural basis for insulin 
bioactivity. The protein is composed of two 
polypeptide chains, the A-chain (21 residues) and the 
B-chain (30 residues). The two chains are covalently 
linked by disulfide bridges at A7-B7 and A20-B19, 
and an intrachain disulfide bridge is joining A6 and 
Al 1. The primary structure of insulin is shown in 
Figure 2.1. 
The three dimensional structure of insulin 
has been characterized in detail by X-ray analysis of 
aggregated species, notably zinc insulin hexamers 
(Adams et al., 1969; Smith et al., 1984; Derewenda et 
al., 1989). The three principal hexamer conformations 
have been designated the Th, T3R.1, and & forms, 
respectively (Raarshohn et al., 1989). In each of these 
structures, the A-chain folds into a helix-loop-helix 
motif with helical stretches located in A2-A8 and 
Al2-A19. The B-chain can assume two distinct 
conformations. In the T-state, the B-chain contains an 
extended N-terminal arm, central a-helix (B9-B19), 
type I turn (B20-B23), and C-terminal p-strand. In the 
R-state, residues Bl -B9 take up a helical conformation 
to form a region of a-helix contiguous horn Bl-B19. 
Figure 2.2 gives a stereographic representation of the 
three hexamer conformations (Wittingham et al., 
1995) 2-zinc (T6), Czinc (TJRxr) pig insulin (the Rf 
form is similar to the R form, but with residues Bl -B3 
disordered) and rhombohedral phenol insulin m,). 
The inter-conversion between the Tg, T3R3, and R, 
states of the insulin hexamer is modulated by a set of 
homotropic and heterotropic ligand binding 
interactions and has been shown to take place in 
solution (Kaarsholm et al., 1989; Brader et al., 1991; 
Bloom et al., 1995). 
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Figure 2.2 Stereographic representation of (upper panel) Z-zinc pig insulin (T& (middle panel) 4-zinc pig 
insulin (T3R3’j and (lower panel) rhombohedral phenol insulin (Et). For clarity only the B-chains are shown, 
and in each dimer, the two B-chains are shaded differently. The positions of the zinc ions (white spheres), BlO 
His sidechains, and phenol ligands (ball and stick) are shown. Adapted from Wittingham et al. (1995) with 
authors permission. The program MolScript was used to make the representations (Kraulis, 1992). 
Although insulin hexamers are extensively 
characterized by X-ray crystallography, the 
physiologically active form of the hormone is the 5808 
Dalton monomer. Hence, in any discussion of 
structure-activity relationships for insulin, it is 
necessary to consider whether crystal packing forces 
have modified the structure from that required for 
biological action. Due to the complicated pattern of 
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insulin self-association in solution. detailed NMR 
analysis of the insulin monomer has often been 
ambiguous. Accordingly, several groups have reported 
results of NMR studies carried out at low pH (i.e.., pH 
1.8-3.5) using either modified insulins, organic co- 
solvents. or both. in an effort to counteract self- 
association (see e.g. Kline & Justice, 1990; Knegtel et 
al., 1991; Hua et al.. 1991, 1992a, 1993b: Jorgensen et 
al., 1992; Ludvigsen et al., 1994). The reported 
structures generally agree that the secondary structure 
of the insulin monomer in solution is similar to that of 
the crystallographically identified T-state. However, 
considerable differences are apparent in terms of the 
structural resolution expressed e.g. by the atomic rms 
values. 
In one extreme, insulin structures with 
properties similar to a ‘molten-globule’ state have been 
reported. On the basis of these structures determined 
in the presence of 20% acetic acid, it has been 
postulated that the lack of tertiary structural detail is 
intrinsic to the native insulin monomer and that the 
phenomenon per se is important for the interactions of 
insulin with its receptor (Hua et al., 1991, 1992a,b, 
1993a,b). In contrast with these low resolution 
structures, our NMR studies on the biologically active 
B16 Tyr + His mutant in water at low pH have 
revealed a well-defined solution structure (Ludvigsen 
et al., 1994; Kaarsholm & Ludvigsen, 1995). Because 
the B16 His mutant remains essentially monomeric at 
millimolar concentrations in aqueous solution at low 
pH, these results identify sample homogeneity and 
aggregation state as major determinants for the quality 
of the NMR-derived structure. 
The high resolution solution structure of 
the insulin monomer at low pH provides an important 
prerequisite for the understanding of the interaction 
between insulin and its receptor. However, a long- 
term goal for these NIvlR studies is to determine the 
structure and dynamics of engineered monomers 
under physiologically conditions as a base line for 
further structural examination of mutations associated 
with enhanced or diminished affinity for the insulin 
receptor. 
Detailed NMR studies of the insulin 
monomer at neutral pH have so far been limited by 
protein solubility and self-association in addition to 
the inherently faster rate of NH exchange in this pH 
region. In the present work we use site-directed 
mutagenesis to manipulate the solubility and 
aggregation pattern of insulin in the neutral pH 
region. These experiments identify a mutant and a set 
of conditions where the monomer is amenable for 
high resolution NMR structural analysis. The 
preferred mutant has glutamate residues substituted 
into four positions. i.e., Bl Phe, BlO His, B16 Tyr, 
and B27 Thr and the C-terminal B30 Thr is removed. 
This mutant retains 47% biological potency and is 
monomeric at millimolar concentrations in the pH 
range 6.5-7.5. The resulting structure is generally 
well-defined as evidenced by a high number of 
sequential NOES as well as many long range NOES. 
Apparent disorder is observed near the termini of the 
B-chain, e.g. Bl-B4 and B27-B29, and is to a large 
extent ascribed to local effects of the mutations. 
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2.3 Materials and methods 
2.3.1 Materials 
Native and mutant insulins were 
constructed by oligonucleotidc-dircctcd mutagenesis, 
fermented in yeast, and purified as described 
(Markussen et al., 1987; Brange et al., 1988). In a 
typical small-scale preparation, the mutant is 
expressed and partly purified as a single-chain mini- 
proinsulin precursor, Bl..B29Lys-Ala-Ala-Lys- 
AlGly..A21. Prior to the final purification step, the 
connecting peptide is cleaved off by treatment with a 
lysyl endopeptidase (Achromobacter Protease I, EC 
3.4.21.50; Wako Inc., Japan), and the mutant insulin 
is isolated in the form of des-B30 Thr insulin. The 
removal of the B30 Thr residue has no effect on the 
biological potency of the molecule. 
2.3.2 CD Spectroscopy 
CD spectra were recorded with a Jobin 
Yvon Mark V dichrograph calibrated with (+)-lO- 
camphorsulfonic acid as described (Kaarsholm et al., 
1993). Near-UV CD spectra were recorded between 
250 and 350 nm using an appropriate combination of 
cell pathlength and protein concentration to yield an 
absorbancy of less than 1. Protein concentrations were 
determined by UV absorbance using ~276~ 6.2 x lo3 
M-‘cm“. The same extinction coefficient was used for 
estimation of the concentration of mutant species with 
the assumption that each of the four tyrosines in 
human insulin contributes 25% to ~276 
2.3.3 NMR Spectroscop! 
Samples were prepared by dissolving the 
lyophilized protein powder in lo!90 DZO HZ0 or 99.8 
% DzO and adjusting the pH as desired by additions of 
small amounts of 1 M DC1 or NaOD. -111 pH meter 
readings are without correction for isotope effects. For 
all NMR experiments reported herein a temperature of 
307 K was used. 
Two dimensional ‘H-‘H NMR spectra, 
DQF-COSY (Piantini et al., 1982: Rance et al., 1983). 
NOESY (Jeener et al., 1979; Anil-Kumar et al., 19S0, 
1981) and TOCSY (Braunschweiler & Ernst, 1983; 
Bax & Davis, 1985) were recorded on a Bruker 
AMX600 spectrometer. For TOCSY and NOESY 
spectra, mixing times were between 40-90 and 120- 
180 ms, respectively. All spectra had a spectral width 
in both dimensions of 6579 Hz: 1024 t: increments 
were acquired each with a size of 2048 real datapoints. 
The spectra were recorded in the phase-sensitive mode 
using the time proportional phase incTementation 
scheme (TPPI, Marion & Wiithrich. 1983). The 
carrier was placed on the water resonance to enable 
inidation of the water during a period of 1.5 s between 
the individual scans. 
Prior to Fourier transformation the FlD’s 
were zero filled once in both dimensions. For 
resolution enhancement of the DQF-COSY spectra. a 
squared sine-bell shifted 90” was med in both 
dimensions, whereas for the NOESY and TOCSY 
spectra, a Gaussian function with an exponential line 
broadening of -7 Hz and a factor of 0.15 was applied, 
Data processing was performed using the MNjfR 
package (PRONTO Soflware Development and 
Distribution, Copenhagen, Denmark) or the Bruker 
UXNMR software on a Silicon Graphics Indigo 
computer. Exchange of amide protons was followed 
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by a series of 8K datapoint one-dimensional spectra. 
These spectra were zero filled once, and a 1.5 Hz line 
broadening was used as a window multiplication prior 
to the Fourier transformation. 
The program PRONTO (PRONTO 
software Development and Distrubution; see Kjrer et 
al., 1991) was used to keep track of spectral 
assignments, cross-peak integration, sequence-specific 
and stereo-specific assignments and related 
bookkeeping during spectral analysis. “JnNua coupling 
constants were measured by the facility in the 
PRONTO software which uses a combined analysis of 
COSY and NOESY spectra (Ludvigsen et al., 1991). 
Chemical shifts were measured in parts per million as 
observed relative to dioxane (3.75 ppm). 
2.3.4 Structure Calculations 
The program X-PLOR (Brtinger, 1992) 
was used to calculate structures based on distance- and 
dihedral angle restraints derived from the NMR 
spectra. Integrated NOESY cross peaks were divided 
into three classes of distance restraints using 1 .O A as 
lower limit and upper limits of 2.7, 3.3 and 5.5 A, 
respectively. For restraints involving methyl groups, 
an additional 0.5 A was added to the upper limit. The 
measured ‘JnNna coupling constants were converted 
into @angle restraints as follows: -6O”* 30” (2-4 Hz); 
-70” f 30” (4-6 Hz); -120” f 60 (6-8 Hz); and -120” + 
35” (8-10 Hz). The stereospecific assignment of 
several 0 methylene protons was obtained by 
combined analysis of COSY cross peak patterns 
(Hybert et al., 1987) and of the intraresidual NOE 
intensities between the methylene protons, the a- and 
the amide protons, respectively (Wagner et al., 1987). 
This method allowed assignment of the side-chain to 
one of the three staggered conformations, XI, 
assuming the values -60” i 60”, 60” + 60”. or 180” f 
60”. Stereospecitic assignment of 6 methyl groups of 
Leu residues were found and converted to ~2 restraints 
in a similar fashion. The structure calculations were 
performed using a combination of distance geometry 
(Crippen & Have], 1988: Kuszewski et al.. 1992) and 
simulated annealing as proposed by Nilges et al. 
(1988). 
2.3.5 Comparison of Solution 
Structures 
From the Protein Data Bank (PDB), Brookhaven 
(January 1996) all files containing structures of 
monomeric native and mutant insulins determined 
by NMR were collected. Each file contains an 
ensemble of structures as well as a representative 
structure. For the purpose of comparison of the 
different structures, geometric average structures 
were calculated from these ensembles of structures 
following the alignment procedures presented in 
the literature references as listed in the header of 
the files. In order to obtain a reasonable 
comparison, we have made one exception to this 
procedure and used both chains rather than just the 
B-chain helix in the alignment of the DPI 
structures. Table 2.3 at the end of this Chapter 
gives a summary of the experimental conditions 
and details concerning the structural calculations 
as referenced in the PDB files and in the original 
publications. The program X-PLOR (Briinger, 1992) 
was used to calculate the average structures. 
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2.4 Results 
2.4.1 Design of a Monomeric Insulin 
Suitable for 2D NMR at Neutral pH 
The aggregation and precipitation pattern 
of insulin is a complex function of protein 
concentration, pH, temperature. metal ions, ionic 
strength, and solvent composition. In the millimolar 
concentration range usually required for high- 
resolution NMR structural work. metal-free insulin 
exists predominantly as dimers and higher oligomers 
at pH 2.0-3.5. At higher pH aggregation increases, 
which in turn leads to precipitation in the pH region 
between 4.2 and 6.6. Above pH 6.6 insulin dissolves, 
presumably as a mixture of dimers and higher 
aggregates, which then gradually dissociate as the pH 
increases. As the pH is raised above 10-l 1, the 
monomeric state is finally reached (JetEey & Coates, 
1966; Pekar & Frank, 1972; Lord et al., 1973; 
Goldman & Carpenter, 1974; Jeffrey et al., 1976; 
Packer & Biswas, 1981; Strazza et al., 1985; Mark et 
al., 1987; Kaarsholm et al., 1990; Roy et al., 1990a; 
Kadima et al., 1992). The X-ray structure of the T6 
zinc insulin hexamer shows that distinct interfaces are 
involved in insulin dimer and hexamer packing 
(Baker et al., 1988). The published equilibrium 
constants for solution aggregation along the 
monomer/monomer &&ace are similar at pH 2 and 
pH 7 (i.e., = 10’ M’). However, the corresponding 
aggregation along the dimer/dimer interface appears 
much stronger at pH 7 than at pH 2 (Mark et al., 
1987). Hence, in contrast with the situation at low pH 
(Ludvigsen et al., 1994), insulin self-association must 
be inhibited along two distinct interfaces in order to 
obtain monomers at millimolar concentrations at 
neutral PH. At the same time, the resulting mutant 
should retain near-native biological potency and the 
soiubility pattern must allow NMR measurement in a 
pH range where the exchange rate of backbone NH is 
sufficiently slow for observation with conventional ‘H- 
NMR techniques (Wiithrich, 1986). 
Aggregation properties of \.arious insulin 
mutants were evaluated by near-W circular 
dichroism (CD) and NMR resonance line widths. The 
near-W CD spectrum (350-250 nml of insulin 
reflects the environment of the tyrosine chromophore. 
The signal is very sensitive to ag-egation and may be 
used to monitor the formation of dimer interface 
(Morris et al., 1968; Goldman & Carpenter. 1974: 
Wood et al., 1975; Strickland & Mercola, 1976). 
NMR spectra are sensitive to insulin self-association 
because longer rotational correlation times lead to line 
broadening and because dynamic equilibria between 
oligomeric states can lead to line broadening in the 
intermediate-exchange r gime. 
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9 a 7 PPm 9 8 7 PPm 
Figure 2.3 ID NMR spectra showing the aromatic and amide proton resonances of native and mutant insulins at 1 
nM protein concentration in lo/90 D10/H20, 307 K. Panels (A): human insulin, pH 7.5; (B): B27 Thr + Glu , pH 
7.5; (C): (3316, B27) Glu, pH 7.5, (D): (Bl, B27) Glu, pH 7.5; (E): BlO Glu, des-B30, pH 7.5; (F)-(H): (Bl, BlO. 
316, B27) Glu, des-B30 insulin at pH 7.5,7.0 and 6.5, respectively. 
Figure 2.3 shows the aromatic and amide 
proton resonances of the 1D ‘H-NMR spectra for 
human insulin (panel A) and a series of mutants 
(panels B-F) at 1 mM protein in IO/90 D20/H10, pH 
7.5. Under these conditions, human insulin exists as a 
mixture of dimers and higher aggregates and the 
resulting spectrum is very poorly resolved. The X-ray 
structure of the T6 insulin hexamer shows that dimer 
formation is dominated by a series of non-polar 
contacts contributed by B-chain residues, notably B12 
Val and B16 Tyr in the central helix, and residues 
B23-B28 in the extended chain. Panels (B-C) 
illustrate the effects of introducing charged residues at 
two different positions in the monomer/monomer 
interface. As shown in Panel (B), the B27 Thr + Glu 
mutation at the edge of the monomer~monomer 
interface effects little or no improvement in spectral 
resolution relative to human insulin. This mutation 
has a minor inhibitory effect on dimer formation 
(Brange et al., 1988); however, in the present study 
the modification is preferred due to its positive effect 
on the expression level in yeast and hence on the 
overall fermentation yield during small-scale mutant 
preparation. Introduction of charge into the B16 Tyr 
position has previously been shown to provide an 
efficient means of inhibiting the formation of dimer 
interface at low pH (Ludvigsen et al., 1994; 
Kaarsholm & Ludvigsen, 1995). In accordance with 
this result, panel (C) shows that the B16 Tyr + Glu 
mutation strongly enhances the spectral resolution at 
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pH 7.5. While the (B16, B27) Glu species is nearly 
monomeric at 1 mM protein. the exchange rate of 
several NH-protons is too fast for observation in 2D 
spectra. At slightly lower pH, extensive line 
broadening is observed in concert with aggregation 
along the dimer/dimer interface. Accordingly, the 
number of cross-peaks observed in 2D NOESY 
spectra of the (B16, B27) Glu mutant is significantly 
smaller at pH 7.0 than at pH 7.5 (data not shown). 
When the TG hexamer is assembled from 
dimers through the coordination of Zn2+ to the BlO 
His residues, both polar and non-polar residues are 
buried between the dimers. The packing is 
correspondingly much looser than in the 
monomer/monomer interface within each dimer. A set 
of important contacts across the dimer-dimer interface 
involves the N-terminal part of the B-chain. Of 
particular interest is the Bl Phe residue, which fit into 
a pocket between the main A-chain and Al4 Tyr 
residue of its neighbor. Because the two Al4 Tyr are 
also in contact across the dimer-dimer interface, a 
close aggregate involving four aromatic residues is 
formed (Baker et al., 1988). Comparison of panels (B) 
and (D) in Figure 2.3 shows that the Bl Phe + Glu 
mutation leads to somewhat improved resolution of 
the 1D NMR spectrum. A slightly better improvement 
is obtained with the BlO His + Glu mutation 
positioned at the edge of the dimer/dimer interface, 
viz. panel (E). 
The BlO His + Glu mutation also has the 
effect of increasing the biological potency of the 
insulin molecule 4-fold as determined by the ability to 
incorporate [2-3H&glucose in isolated mouse 
adipocytes according to Moody et al. (1974). In the 
same assay, the B27 Glu, (Bl, B27) Glu, (B16, B27) 
Glu and des-B30 insulins exhibit potencies of 1.07, 
0.97,O. 13 and 1 .OO, respectively, relative to a value of 
Insulin Structure 
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Figure 2.4 Near-UV CD spectra as a function o 
Jrotein concentration. (A): zinc-free human insulin ii 
10 mM TrisiClO~, pH 8.0, and ( . . . .) 5 PM, (-- - 
10 FM, (- - -) 200 PM, and ( -) 2 mM protein 
:B) and (C): (Bl, BIO, B16, B27) Glu, des-B3t 
nutant insulin in 25 mM Tris/ClO,; pH 7.5 (B) ant 
25 mM phosphate, pH 6.5 (C), and ( . . . .) 50 PM, 
‘- - -) 600 uM and (- ) 2.6 mM nrotein. 
1 .OO found for human insulin. For the mutant carrying 
all modifications, i.e. (Bl, BlO, B16, B27) Glu, des- 
B30 insulin a relative potency of 0.47 is found 
indicating that the substitutions affect the biological 
activity in a nearly independent manner. Panel (F) in 
Figure 1 shows that the 1D spectrum of (Bl, BlO, 
B16, B27) Glu, des-B30 insulin is well-resolved and 
retains the dispersion of resonance lines characteristic 
for globular proteins. Furthermore, as the pH is 
adjusted down to 7.0-6.5, the high resolution is 
maintained (panels (G) and @I)), while selected NH 
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resonances become sharper as expected due to the 
slowed exchange rate. 
Figure 2.4 shows near-UV CD spectra as a 
function of protein concentration for native insulin at 
pH 8.0 and the (Bl, BlO, B16, B27) Glu, des-B30 
mutant at pH 6.5 and 7.5. For native insulin, the 
progressive increase in intensity of the negative signal 
around 274 nm indicates the expected increase in 
association with increasing concentration. In contrast, 
the near-UV CD spectrum of the mutant is 
independent of the protein concentration in the 60 uM 
to 2.6 mM range at both pH 6.5 and 7.5. Although the 
mutant is missing one tyrosine reporter group (B16), 
Tyr B26 is expected to be strongly affected by 
monomer/monomer interactions. Hence, these results 
provide further evidence that the (Bl, BlO, B16, B27) 
Glu, des-B30 mutant is monomeric under conditions 
necessary for NMR structural studies at neutral PH., 
and this species was selected for detailed 
characterization. 
2.4.2 Assignment of Spin Systems 
NMR spectra were assigned using the 
standard procedures outlined by Wtithrich (1986). The 
fingerprint region of the DQF-COSY spectrum is 
shown in the upper panel of Figure 2.5, The chemical 
shifts are dispersed and well-resolved as expected for a 
structured globular protein, and 37 of the 47 possible 
H5-P cross peaks are annotated in the plot. Among 
the remaining HNH* cross peaks, six were assigned 
using TOCSY spectra. These are the resonances that 
are either close to the water line or unusually broad, 
i.e., A8, A9, A12, B5, B6, and B26. The linewidth of 
the CysAll amide proton is unusually broad, but 
identification was possible in DQF-COSY spectra. 
Amide protons from residues A2, B6 and B9 were not 
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Figure 2.5 Sections from the DQF COSY spectrum 
:top) and NOESY spectrum (mixing-time 180 ms) 
lbottom). The fingerprint region of the DQF COSY 
spectrum shows the major part of the correlations 
>etween a-protons and amide protons that was 
.dentified. The correlations between amide protonr 
indicative of helical areas in the structure art 
annotated in the bottom panel, and lines are drawr 
to follow the amide protons throughout the helices. 
identified. Finally, for the side-chains of Glu and Gln 
residues, considerable overlap of cross peaks in the 
HP-W area was resolved using TOCSY spectra 
occasionally supported by NOESY. 
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Figure 2.6 Summary of the data used for sequential assignment and determination of secondary 
structural elements. The thickness of the bars indicates the intensity of the NOES as measured in a 
NOESY spectrum with a mixing-time of 150 ms. The coupling constants and the xl dihedral angles 
were measured as desribed in Materials and Methods. The filled circles indicate that the amide proton 
signal is observable in a 1 D spectrum at least 12 minutes after dissolution of the sample in D1O. The 
last row shows the chemical shift index, CSI, (Wishart et al., 1992) of the a-protons. 
Table 2.1 at the end of this Chapter contains a list 
of the ‘H chemical shifts of the insulin mutant. 
2.4.3 Sequential Assignment and 
Secondary Structure 
The sequential assignment was 
straightforward for most parts of the insulin 
mutant. Including the regions B9-B29, A9-A12, 
and Al 3-A2 1. The assignment of the stretch from 
A4 to A8 was complicated by overlapping H-” and 
II? resonances; this is reflected in the lack of 
sequential NOES as well as NOES indicative of 
secondary structure in this region. In the S- 
terminus of the B-chain, the NOES are sparse and 
the assignments here were made by exclusion as 
the very last part of the procedure. 
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The first indications of the secondary 
structures come from inspection of the chemical 
shifts of the a-protons compared to the random coil 
values (Wishart et al., 1992). The chemical indices 
shown in Figure 2.6 suggest helical structures 
characterized by upfield shifts of the o-protons in 
the second part of the A-chain (the A(B)-helix) and 
in the central part of the B-chain (the B-helix), 
whereas the helix expected in the N-terminus of 
the A-chain (the A(I)-helix) seems less well 
defined. These observations are substantiated by 
the NOES assigned in the same regions as shown 
in Figure 2.6 and in the NOE matrix in the lower 
panel of Figure 2.7. 
The B-helix, stretching from B9 to B19, is 
a well defined helix characterized by a dense 
network of NOES between the a-protons in 
position i and the amide protons in position i-+3 
and position i+4 as well as the P-protons in 
position i+3. Furthermore, stronger NOES between 
amide protons 2 residues apart in the helix are 
found. The C-terminal A(II)-helix comprising the 
amino acids from Al3 to A20 has a less dense 
network of NOES, i.e., only between a-protons in 
position i and p- and amide protons in position 
i+3. The N-terminal A(I)-helix stretches from A2 
to A6 and is characterized by the same type of 
NOES as the A(B)-helix. In the lower panel of 
Figure 3, the HN to HN part of the NOESY 
spectrum is shown with annotations for the 
sequential assignment of the helical areas. 
An amide proton characterized by an 
exchange rate slower than the average is a good 
evidence for participation in a hydrogen bond 
either in a secondary structural element or as part 
of the tertiary fold of the protein. At near neutral 
B25 
820 
Bl5 
BIO 
B5 
A5 Al0 Al5 A20 Bj BIO 815 1320 1325 
AZ0 
A15 
AI0 
A5 
A5 A10 Al5 A20 85 BIO 815 820 825 
Figure 2.7 The upper panel shows the distribution of 
?TOEs by residue, intraresidual NOES are marked with 
filled boxes and interresidual NOES with vertical lines. 
ln the matrix in the lower panel filled circles indicate 
:he presence of at least one NOE between the 
connected residues. Multiple occurences of NOES on 
both sides of the diagonal in a spectrum or in different 
spectra were filtered out before the conversion tc 
distance restraints. The presence of helical regions, as 
expected from the patterns of NOES, is indicated. 
pH, the exchange rate of amide protons is in the 
order of IO2 min-’ (Englander et al., 1972). From 
1D proton spectra recorded in the period between 
12 and 60 minutes after dissolution of the insulin 
mutant in DzO, it is possible by visual inspection to 
follow the decay of amide proton resonances 
belonging to the B-helix and the A(B)-helix as well 
as a single amide proton in the A(I)-helix. After 50 
minutes, all amide protons are exchanged by 
deuterons. The locations of the slow exchanging 
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Figure 2.8 The backbone of 25 converged structures of the insulin mutant superimposed together with 
heir geometric average. The average structure is represented by a ribbon, the A-chain is shown in red, 
the B-chain in blue. The structures are aligned in the regions B4-B26, A2-A 19. 
, amide protons according to this criterion are shown 
in Figure 2.6. 
2.4.4 Structure Calculations 
Table 2.2 lists the number of distance 
restraints and dihedral angle restraints used for the 
final structure calculations. In addition, the sultide 
bridges were added as distance restraints, while no 
restraints were added for hydrogen bonds. The 
matrix in the lower panel of Figure 2.7 shows the 
distribution of NOES between residues. Multiple 
occurences of NOES from both sides of the 
diagonal in a spectrum or from different spectra 
were filtered out before the conversion of NOES to 
distance restraints. As a supplement, the upper 
panel of the same Figure depicts the number of 
NOES by residue. The distribution of dihedral 
angle restraints on residues is shown in Figure 2.6. 
The calculation of structures using X-PLOR 3.0 
proceeded as described in Materials and Methods 
starting from a reduced set of distance restraints. In 
a sequence of iterations, this set was slowly 
expanded as ambiguities could be resolved, and 
finally the dihedral angle restraints were 
introduced. A total of 100 structures were 
calculated 25 of which were characterized by 
distance restraints violations below 0.3 A, dihedral 
angle restraints violations below 2”, and a low total 
energy. Table 2.2 summarizes the structural 
statistics for this set of structures. 
The set of 25 converged structures is 
depicted in Figure 2.8 (backbone representation) 
together with their geometric average represented 
by a ribbon. In Figure 2.9, the side-chains have 
been included, and the average structure shown 
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B25 
Al i, 
?igure 2.9 The geometric average structure of the insulin mutant colored according to atomic rms. The 
iverage structure was calculated based on alignment of residues B4-B26 and A2-Al9. 
here is colored according to the atomic rms 
deviation. 
2.4.5 Description of the Structures 
The major part of the mutant structure is 
well-defined. This goes indeed for the B-helix (B9- 
B19) which exhibits low rms deviation among the 
structures as expected from the large number of 
structural NOES as well as the small coupling 
constants, indicative of helix structure. The 
hydrogen bonds fit a regular a-helix pattern all the 
way starting from B9(CO)*.*B13(HN) and ending at 
the last donor B19(HN). 
At the C-terminal end of the helix, a type 
I turn from B20 to B23 turns into a 0 strand that 
stretches along the central helix. The three C- 
terminal residues are disordered. As is evident 
from Figure 4, no NOE structural information was 
obtained in the Bl-B4 region of the B-chain. This 
fact is reflected in the random distribution of the 
termini among the 25 structures presented in 
Figure 2.8 and implies that the average structure 
calculated in this area is physically meaningless. 
The A(B)-helix (A13-A20) shows a high degree of 
accordance within the bundle of structures, and the 
hydrogen bonding pattern tits an a-helix 
Al3(CO)**.Al 7(HN), Al 5(CO)-*-Al 9(HN), and 
A16(CO)***A20(HN), starting out with the irregular 
A12(CO)a.*A15(HN) hydrogen bond. The A(1) 
helix (A2-AS) is a little less well-defined, a single 
hydrogen bond between A2(CO) and A6(H”) is 
established. The loop area (A9-A12) connecting 
the two A-chain helices shows a larger spread of 
conformations. In 20 out of 25 calculated structures 
the interchain hydrogen bond A 1 9(CO)***B25(HN) 
is established, in agreement with crystal structures. 
The atomic rms deviations calculated are presented 
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in Table 2.2 along with the general structural 
statistics. 
2.5 Discussion 
The (Bl, BlO, B16, B27) Glu, des-B30 
mutant is the first example of an insulin species that 
remains monomeric at millimolar concentration in 
aqueous solution at neutral pH. Hence, by tailored 
mutations in two dins& protein/protein interfaces, 
the inherent self-association of insulin is strongly 
inhibited, while the biological potency is essentially 
retained. As a result, samples may be prepared under 
conditions where the exchange rate of backbone amide 
protons is sufficiently slow for detailed NMR analysis. 
Previous NMR investigations of native and mutant 
insulins at near-neutral pH have been limited by 
incomplete assignments of the spectra. Nevertheless, 
on the basis of 1D spectra of human insulin at high 
dilution and of the B9 Ser --+ Asp monomeric mutant 
in the pH 8-9.5 range, Roy et al. (1990a,b) were able 
to show that the association of insulin monomers into 
dimers is accompanied by a change in conformation 
involving the relative position of residues B15 Leu 
and B24 Phe. In their NMR analysis of the BIO Asp, 
B28 Lys, B29 Pro (DKP) insulin monomer at pH 8.0, 
Weiss et al. (1991) also reported partial assignments 
and employed selective ‘H and 13C labeling of the 
B23-B26 residues to confirm that this region is indeed 
in close contact with residues from the central B-chain 
helix. 
The (Bl, BlO, B16, B27) Glu, des-B30 
mutant is structurally well-ordered with the exception 
of the B-chain &mini, i.e., residues Bl-B4 and B27- 
B29. The observed disorder in the N-terminus is most 
reasonably ascribed to opposing effects of the Bl and 
BlO mutations. Removal of the hydrophobic Bl Phe 
side-chain destabilizes the packing of the Bl residue 
against the Al3 Leu region (Ludvigsen et al.: 1994) 
while the BlO Asp side-chain caps the central B9-B19 
helix and hence stabilizes the T-state relative to the R- 
state (Kaarsholm et al., 1993). In any event, because 
the B-chain helix is clearly confined to residues B9- 
B19, the overall structure resembles a crystallographic 
T-state more than a R-state. In the C-terminal B29- 
B30 residues, disorder is observed in the crystal 
structure as well as in the lo\v-pH solution structure 
(Baker et al., 1988; Ludvigsen et al.. 1994). ln the 
present work at neutral PH. the lack of structural 
definition extents to the last three residues, B27-B29. 
Again, the effect is most likely due to the 
modifications employed, i.e.. the introduction of 
negative charge close to the shortened C-terminus 
(I327 Thr + Glu, des-B30). In accordance with 
previous work (Kline & Justice, 1990; Ludvigsen et 
al., 1994), broad amide proton resonances are 
observed in the A-chain loop region suggesting that 
conformational substates exchange on a millisecond 
time scale in this particular region. 
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Figure 2.10 Ensemble averages of three dimensional structures of native (HI) and mutant insulins determined 
by NMR. The sts-nctnres are color coded according to the atomic root mean square deviation of the backbone. 
For further details, see Table 2.3. 
2.51 Comparsion with Other Monomer 
Solution Structures 
Several NMR investigations of insulin 
monomers have been carried out at low pH and/or in 
the presence of organic co-solvent. Table 2.3 
compares experimental conditions and details 
concerning the structure calculations for the (I31 , Bl 0, 
B16, B27) Glu, des-B30 mutant and for other insulin 
monomer strnctnres deposited in the Brookhaven Data 
Bank. In addition to these monomers, the structure of 
a B9 Asp insulin dimer has been described (Jorgensen 
et al., 1992), and the low-pH structure of DPI has been 
determined by Knegtel et al. (199 1) as well as by Hua 
et al. (1992a). Figure 2.10 compares the three 
dimensional structure of (Bl, BlO, B16, B27) Glu, 
des-B30 insulin with those of the other monomers. 
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The structures are color coded according to the atomic 
rms deviations characterizing each of these ensemble 
average structures. Table 2.3 contains details 
concerning the average structure calculations, 
alignment procedures and rms deviations of the 
backbone calculated by using the same alignment 
procedure for all mutants. Note that for certain parts of 
these structures, distance restraints containing 
information about secondary and tertiary fold are 
either absent or very few in number. This is 
particularly true for the C-terminal B22-B30 residues 
of the B24 Gly and B24 Ser mutants (Hua et al., 199 1, 
1993b). As a result, considerable atomic rms 
deviations are obtained which make the average 
structures physically meaningless in these parts 
colored red in Figure 2.10. Paradoxically, a distinct 
bulge appears on the C-terminal p-strand of the B24 
Set- structure. 
The precision of the individual structures is 
quantified by the ensemble average rms deviations in 
Table 2.3. A comparison of the two columns of 
backbone rms deviations in the Table reveals that 
most of the differences are caused by imprecision of 
the C-terminal of the B-chain. The B16 His structure 
shows the highest degree of overall accordance 
between the individual structures in the ensemble. In 
this case, the presicion is directly correlated with the 
number of interresidual distance restraints used in the 
structure calculation. However, due to differences in 
the procedures for counting of the NOES and for the 
translation of NOES into distance restraints, the 
correlation between structural precision and the 
number of NOES is generally not straightforward. The 
high precision of side-chain structures in B16 His 
insulin are closely related to the number of 
assignments of xi and ~2 dihedral angles. The 
individual monomer structures are compared one by 
one in Table 2.4 at the end of this Chapter. It is clear 
that the B16 His insulin has the closest structural 
resemblance to the (B 1, B I 0, B 16, B27) Glu, des-B30 
mutant. The major difference between these two 
structures is the lack of definition of residues Bl -B4 in 
(Bl, BlO, B16, B27) Glu, des-B30 insulin. In B16 His 
insulin, the close contact between B-chain N-terminus 
and the A-chain loop region provides the set of NOES 
defining the spatial arrangement of the loop. Thus, the 
lack of structure in residues Bl-B4 propagates to an 
increased inpresicion of the A-chain loop region in 
(Bl, BlO, B16, B27) Glu, des-B30 insulin. 
Finally, we note that with the exception of 
the B-chain termini, the structures depicted in Figure 
9 share common features including the secondary 
structure elements and the overall spatial arrangement 
of these elements into the tertiary structure. As would 
be expected for a globular protein, Table 2.3 shows 
that each structural core is character&l by a low rms 
deviation (high precision) relative to the precision of 
the overall structure. In contrast with these 
calculations, Hua et al. (1992a, 1993a) reported that 
variations in the mutual spatial arrangement of the 
two chains in the case of DPI span the differences 
reported among various insulin crystal forms. The 
phenomenon was ascribed to the absence of restraints 
and interpreted as evidence that DPI exists in a 
‘molten globule’ state under native-like conditions 
(Hua et al., 1992a, 1993a). A molten globule state is 
usually characterized as a compact denatured state 
arising as an intermediate in the pathway from native 
to unfolded protein under slightly denaturing 
conditions (see e.g. reviews by Dobson (199 1,1992)). 
The state is characterized by the presence of secondary 
structural domains. but absence of tertiary 
interactions, i.e., the conformation of the side-chains 
is essentially random. In a NMR spectrum, one feature 
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of a molten globule state would be a reduced 
dispersion of side-chain resonances in comparison 
with the native state (Goto & Fink, 1989). The 
original alignment of the DPI ensemble presented by 
Hua et al. (1992a) was based on a subset of the 
structure, i.e., the central B-chain helix (residues B9- 
Bl9). This procedure per se leads to an accumulation 
of the overall structural imprecision in the parts that 
are left out of the alignment, in this case the entire A- 
chain and the B-chain termini. In contrast, our 
alignment procedure (Table 2.3) is based on both 
chains leaving out only those parts of the molecule 
where the number of restraints per residue is well 
below the average, i.e., the outermost parts of both 
chains. The same procedure was used by Knegtel et al. 
(199 1) for the alignment of DPI. With this procedure, 
the major part of all molecules (including DPI) exhibit 
reasonably well-ordered secondary and tertiary 
structure. For the (Bl, BlO, B16, B27) Glu, des-B30 
mutant at neutral pH and the B16 His mutant at low 
pH, the dispersion of side-chain resonances 
corresponds to that expected for a packed, globular 
protein. Furthermore, both mutants exhibit a distinct 
near-UV CD spectrum very similar to that of native 
human insulin (Figure 2 and Ludvigsen et al., 1994). 
Hence, there seems to be no evidence coming from 
NMR or CD to support the idea that insulin mutants 
exist in a molten globule state characterized by 
variations in the mutual arrangement of the chains. 
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2.6 Supplements 
Insulin Structure 
rable 2.1 ‘H chemical shifts of the insulin mutant at pH 6.5 and 307 K measured in ppm 
elative to dioxane (3.75 ppm)’ 
ksiduc II\: II, IllI others 
\I 6 ly 
\2 Ilc 3.9s I .23 Il.,, 1.2210.95 ll.:O.77 II,, O.U! 
\3 val 8.24 3.66 2.03 I I.!, 0.97 l-l,1 I .03 
\4 Glu 8.34 4.21 2.23.2.1 I I Ii 255’2.33 
\5 Gin 8.18 4.15 2.22 l-l, 2.4812.56 l-l, 7.0117.52 
i6 CYS 8.33 4.96 2.9W3.37 
47 CYS 8.32 4.91 3X2/3.38 
is Thr 8.18 4.20 4.49 H,> 1.320 
49 Ser 7.43 4.80 4.09,3.95 
\I0 Ile 7.85 4.5 I I .70 l-l,, 1.2910.72 H.: 0.78 IH, 0.66 
41 I CYS 9.53 5.08 3.4313.14 
II2 Ser 8.36 4.17 4.05,4. I9 
II3 Leu 9.05 4.08 I .60,1.75 H, I .76 Hri, I .OO l.l<<l 0.91 
414 Tyr 7.81 4.44 3.1 l/3.13 Ho 7.23 H, 6.96 
\15 Gln 7.58 4.12 2.37.2.16 H, 2.4812.32 H, 6.8517.45 
iI6 Leu 7.88 4.18 I .5 l/2.07 H, I .85 H,+ 0.80!0.84 
417 GlU 7.9 I 4.32 2.11 l-l7 2.3U2.45 
418 ASIl 7.44 4.57 2.65,2.71 Hn 7.2416.68 
419 TY~ 8.05 4.42 3.55,2.89 Hh 7.37 H,: 6.87 
420 CYS 7.33 5.29 2.90,3.43 
421 Asn 8.08 4.58 2.8712.15 Hn 6.4517.49 
31 Glu 
32 Val 4.19 2.17 HI I .01/l .04 
B3 Asn 8.61 4.82 2.87l2.84 HA 6.8917.59 
B4 Ciln 8.09 4.54 2.0012.20 HY 2.34 Hs 7.49i6.91 
B5 His 8.42 4.7 I 3.2613.57 Hn2 7.24 H,, 8.29 
B6 Leu 8.81 4.6 I 1.00/l .76 H, 1.64 Hhl 0.85!0.91 
B7 CYS 8.61 5.00 3.05,3.27 
88 GlY 8.13 4.28 
B9 Ser 4.23 4.09i4.03 
BIO Glu 8.21 4.19 2.32.2.16 H, 2.4512.52 
Bll Leu 7.11 4.02 1.89,1.24 H, 1.32 Hs0.76 
B12 Val 7.13 3.31 2.18 Hr, I .04 Hy2 I .09 
B13 Glu 7.91 4.07 2.10 HI 2.5112.33 
Bi4 Ala 7.56 4.19 1.49 
B15 Leu 8.03 3.16 0.28,1.09 H, 1.33 H&r 0.35 Hnz 0.66 
816 Glu 8.29 4.23 2.3212.69 H.,2.41/2.12 
B17 Leu 7.61 4.23 I .89,1.77 H<i, 0.99 H,i: 0.74 
BIS Val 8.38 3.85 2.09 H,, l.l2H,~0.97 
B19 CYS 8.87 4.92 3.01,3.40 
B20 61~ 7.87 4.1 l/4.09 
B2l Glu 9.19 4.27 2.17 H., 2.2712.45 
B22 A% 8.14 4.23 2.1612.29 HY I .97 Hh 3.49,3.43 H,: 7.35 
B23 GUY 7.36 3.9414.23 
B24 Phe 7.6 I 5.36 3.42,3.02 Hh 6.90 H,: 7.28 H; 7.38 
B25 Phe 8.65 4.96 3.2513.32 Hh 7.37 H,: 7.44 
B26 Tyr 8.07 4.12 3.06/3.00 I-l& 7.01 H,: 6.74 
B27 Glu 7.84 4.17 2.1011.94 HI 2.30 
B28 Pro 4.31 2.25 H,, 2.03 Hy> 2.12 Hfi, 3.19 H<: 3.63 
829 LYS 7.82 4.24 I .77.1.90 H, 1.00/l .46 H<< 1.74 H, 3.02 
a Methylene protons with stereospecific assignment are seperated by a comma, HI%, is listed first. 
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able 2.2 Structural statistics 
Distances and torsion anyle restraints 
intra residual 2Y7 0 34 
shon range 1’); XI I4 
long ran@! 51 X? 5 
cross chain 56 
van der Waal energv measured with CHARtiM Dotential (kcal/mol) 
van der Waal -70.4 i I I.8 
Deviations from Ideal Geometry 
Bond (A) 0.0017 ? fl.000I 
Angle (deg) (I.35 i 0.02 
Improper(deg) (I.26 + 0.04 
NOE (A) 0.012 t 0.002 
Torsion (A) 0.2Y i. 0.05 
Averane no. of NOE violations 
backbone(all) 
heavy atoms(all) 
backbone(ASAIY) = 
backbone(B4-B26) ’ 
backbone(AZ-Al9.BCB26) c 
‘Force constant for distance and torsion angle restraints we IO kcal mol.‘A-‘ and 20iJ kcal mot .’ 
radian -.’ 
bCHARMM potential (Brooks et al.. 19X3) used for van der Waal energy’ calculation 
‘Alignment of AZ-AI9 and 84-826 backbone 
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Table 2.4 Comparison of solution structures of human insulin and mutantsa. 
HI 
B16 His 
(BI.BIO,BIG.B27) 
Glu, des-630 
0.33 I.10 1.31 1.27 1.09 I .0x 
1.20 1.54 I.14 1.49 1.09 0.84 
1.16 1.35 I.18 1.35 1.08 0.84 
a The root mean square deviations of the backbone were determined aligning the regions A2-A19, B4-B19 
above the diagonal and the helix regions A2-AS, A13-A19, B9-B19 below the diagonal. The structures are 
ensemble averages aligned as listed in Table 2.3. 
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3. Backbone Dynamics 
The three dimensional solution structure 
of the (Bl, BlO, B16, B27) Glu, des-B30 insulin 
mutant at neutral pH was determined and 
compared to the solution structure of several other 
insulin mutants determined at acidic pH in Chapter 
2. Common of all these insulin structures is the 
conservation of the secondary and tertiary structure 
in the core of the molecule. However, the overall 
precision of the structures in the conserved region 
as well as in the rest of the molecule, the B-chain 
terminal parts, differs widely. The neutral pH 
structure as compared with the other structures 
showed the resemblance to the B16 His mutant 
determined at acidic pH (Ludvigsen et al., 1994, 
Kaarsholm & Ludvigsen, 1995) to be the best. 
However, although the overall precision of the 
neutral pH structure is second best among all 
structures (0.52 A for the backbone in the A2-A8, 
Al2-A19, B5-B27 region) there is still a gap to the 
best, the B16 His mutant (0.33 A in the same 
region). The difference in number of distance 
restaints (observed NOES) used in the two structure 
calculations explains part, at least, of the difference 
between the overall precisions of the final 
structures. To investigate whether this lack of 
NOES is directly related to a more pronounced 
inherent internal dynamic of the insulin mutant at 
neutral pH, the relaxation properties of the 
backbone “N nuclei of both mutants are examined 
here. In ‘the model free approach’ introduced by 
Lipari & Szabo (1982a,b) the lSN relaxation 
parameters, T,, T2, and the {‘H”N) NOE, are 
translated to a generalized order parameter, S2, 
describing the spatial restriction of ‘H”N-bond 
motions on the picoseconds-nanoseconds time 
scale. Motions on the milliseconds timescale are 
mapped as well. 
3.1 Theory of relaxation 
The relaxation mechanism of the amide 
“N nucleus in a protein backbone is a combination 
of dipolar interactions with the directly attached 
amide proton and chemical shift anisotropy. 
Compared to the relaxation mechanism of the 
proton it is pleasingly simple. The longitudinal 
relaxation rate RI and the transversal relaxation 
rate R2, the reciprocal of T1 and TZ respectively, 
are simply sums of the terms for dipolar interaction 
(DD) and chemical shift anisotropy (CSA), cross 
correlation between the two mechanisms is 
neglected. 
(1) 
(2) 
The extra term added in eq 2 accounts fi or 
contributions to the transversal relaxation from 
pseudo first order processes, i.e., conformational 
exchange, the time scale is milliseconds to seconds. 
The relaxation rates and the ‘H-“N nuclear 
Overhauser effect, NOE, are related to the spectral 
density function, J (Abragam, 1961, Lipari & Sza- 
bo, 1982a,b). The spectral density function is the 
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Fourier transformed correlation timction of the 
motion of a unit vector along the NH bond. The 
spectral density function is thus the “spectrum” of 
the characteristic reorientations giving the 
frequency of these. 
1 
-$(&I,, 
,? 
r,- 4 
-co,~)+~J(w,~)+~J(w,, +w/,/))++i(w,) (3) 
1 
- = 54J(O) + 4J(o H 
q 8 
-u>N)+3J(oN)+6J(co,,)+6J(o,, +q)) 
+ $(3J(@,) + 4J(O)) (4) 
YH d' NoE=1+T,-g(6J(w,+w,)-J(w,-w.)) 
YN 
with the constants c and d given by 
d= h& YHYN -- 
8x.’ r& 
h is Planck’s constant (6.626*10-“4 Js), p0 is the 
vacuum permeability (4n*lO-’ TmKl), YH and YN 
are the gyromagnetic ratios of the two nuclei 
(2.6752*108 and -2.7108*107 s-’ T“), rXH is the 
bond length (1.02 A), and CT,, -crl is the difference 
between the components of the chemical shift 
tensor parallel and perpendicular respectively to 
the field (-160 *lo-‘, Hiyama et al., 1988). 
In the model free approach introduced by 
Lipari & Szabo (1982a,b) J is approximated by 
introduction of a generalized order parameter, S2, 
and an effective correlation time for the fast 
internal motion, r,< 0.3 nanoseconds. The overall 
tumbling of the molecule is assumed to be 
isotropic, i.e., characterized by a single correlation 
time, TV, in the nanoseconds time scale. 
(7) 
The generalized order parameter is a measure of 
the degree of spatial restriction of the NH-vector 
motion. S2 takes the value of 1 for complete 
restriction of the motion and the value of 0 for 
completely unrestricted motion. The strength of 
this approach is that these parameters are 
introduced without employing a specific model for 
the internal motion. Figure 3.1 is a graphical 
a 1 
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T>(S) 
--- I 
0.0 1 I 
-1.6 ‘.-i 1 
13 12 11 10 9 8 I 
-I@&) 
T2(S) 0.6 
0.4 -------- 
-T,,S2=1.0 -T S*=l.O 
- - T,,S=O.S - - T3=0.8 
-NOE,S2=1.0 
- - NOE,S*=0.8 
-m -T,,S=0.6 - m -T,,SZ=O.6 - - -NOE,F=O.6 
-m - T,,SZ=O.4 - = - T,,S*=O.4 - - - NOE,S*=0.4 
m m . - T,,P=0.2 - - - - T,,S2=0.2 - - - - NOE,S*=0.2 
Figure 3.1 T1, Tz, and NOE vs. the correlation time, ‘cc, for internal motion of the NH-vector. Each graph 
;hows the dependency on the general order parameter, S2, at five different values. The left hand side of thy 
igure corresponds to 2,=4.98 ns, as for the insulin mutant at acidic pH, the right-hand side corresponds tc 
;f2.86 ns, as for the insulin mutant at neutral pH. 
representation of the relaxation rate constants T1 
and Tz and the {lHISN) NOE vs. the effective 
correlation time for internal motion, 7,. Two 
different correlation times for overall rotational 
tumbling are shown corresponding to the values 
found for the two insulin mutants examined in the 
following section. The data has been calculated (eq 
3-5,7), disregarding conformational exchange line 
broadening, for five different values of S2 ranging 
from completely restricted motion, S2=1.0, to 
almost unrestricted motion, S2=0.2. 
Inspection of the graphs shows that in the time 
range from 1 to about 50 picoseconds and for non- 
extreme S2 values (0.6-l.O), the T1 and T2 graphs 
are independent of the exact value of z, and the 
NOE is at a maximal value dependent only on z,. 
This situation corresponds to a reduced form of the 
spectral density function where the dependence of 
the correlation time for the internal motion, z,, is 
lost. 
I I 
(8) 
I I 
Note again that the simplified spectral density 
function is applicable in the time range ~50 ps, 
giving Tr and T2 values dependent only on S2 ( and 
z, ) and a NOE at its theoretical maximum 
independent of S2. Figure 3.3 is a slice of Figure 
3.1 in the l-50 picoseconds region in the S2 
dimension to show Tr and T2 (eq 3-4) calculated 
using the reduced spectral density function (eq 8). 
The NOE is not shown. 
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Figure 3.2 Relaxation rate constants TI and Tz an 
‘H-“N NOE for the ‘.‘N nucleus (eq 3-5) vs. th 
correlation time, r,, for overall isotropic tumblin 
of the molecule. T,, T?, and rr are measured i 
seconds. The reduced spectral density function (e 
8) was used. 
Figure 3.2 is the classical picture of the relaxation 
times and the NOE vs. the correlation time for 
overall isotropic tumbling (eq. 3-5,8) fixing S’ to 1, 
i.e., assuming total restriction of the internal 
motions. The correlation times for proteins assume 
nanoseconds values giving a positive NOE and Tr 
and Tz in the range of 0. l-l .O s. 
An extension to the model free approach 
was introduced by Clore et al. (199Oa,b) taking 
internal motions on two different time scales into 
account. The slower motion is described by a 
generalized order parameter, S,‘, and a correlation 
time, r,, the rapid motion is described by a 
generalized order parameter, Sf2. 
Figure 3.3 Relaxation rate constants Tt and Tz 
IS. the general order parameter, S’, for the 
nternal motion of the NH-vector. The reduced 
;pectral density function, (eq 8) was used for two 
different rr values. The left hand side corresponds 
o 5, =4.98 ns, as for the insulin mutant at acidic 
)H, giving a theoretical ‘H”N NOE of 0.79. The 
sight hand side corresponds to ~~ =2.86 ns, as for 
:he insulin mutant at neutral pH, giving a 
:heoretical ‘H”N NOE of 0.70. 
orders of magnitude, i.e., r’, is in the nanoseconds 
time scale whereas the faster motion is 
characterized by a correlation time < 10 ps. Note 
that this extended spectral density function (eq 9) 
reduces to the original function (eq 6) if St-’ takes 
the value of 1. 
3.1.1 Models 
The model free approach extracts dynamic 
information from the relaxation rate constants and 
the NOE. The output is an order parameter, S’ 
generalized to cover the broad range of possible 
motions, and a corresponding correlation time, r’,. 
A feasible interpretation of S’ in the relaxation of 
backbone amides is the random motion of the NH- 
vector within a cone of semiangle 0 as shown in 
Figure 3.5, (Clore et al., 1990a). S’ is related to 8 
through 
In order to be resolvable in an NMR experiment. 
the two correlation times must differ by at least l-2 
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Figure 3.4 Generalized order parameter S’ 
4s cone semiangle 8 according to eq 10. 
r I 
s' =(0.5c0stq1+c0s8)) z (10) 
I I 
A graphical representation of eq 10 is shown in 
Figure 3.4. 
The extended spectral density function (eq 
9) introduces an extra order parameter. Clore et al. 
(1990a) suggest that the fast motion corresponds to 
the free diffusion in a cone (eq 10) and the slower 
motion to jumps between different orientations of 
the cone. 
3.2 Materials and Methods 
3.2.1 Materials 
Two mutants of human insulin were 
constructed by oligonucleotide-directed muta- 
genesis. The rationale behind engi-neering these 
mutants has been described elsewhere (Ludvigsen 
et al., 1994, Chapter 2) The fermentation in yeast, 
using ‘%I-L&l as the source of “N, gave uniformly 
enriched samples which was purified as described 
(Markussen et al., 1987; Brange et al., 1988). The 
mutants, B16 His, des-B30 and (Bl, BlO, B16, 
Figure 3.5 Model of NH-vector motion in a 
cone. 
B27) Glu, des-B30 were dissolved in 80% Hz0 / 
20% DzO to a concentration of approximately 2.5 
mM at pH=2.4, 24°C and at pH=6.5, 34°C 
respectively. 
The three dimensional structure of the 
B16 His mutant has been determined by NMR 
(Ludvigsen et al., 1994, Kaarsholm & Ludvigsen, 
1995) and the result is deposited in The Protein 
Data Bank, Brookhaven. The three dimensional 
structure of the (Bl, BlO, B16, B27) Glu, des-B30 
mutant was presented in Chapter 2. The average 
structures shown here has been calculated from 
ensembles of structures aligning the regions A2- 
A 19 and B4-B27 simultaneously. 
3.2.2 NMR Spectroscopy 
The measurement of relaxation rate 
constants of the insensitive ‘?N nucleus and 
( ‘H”N] NOE is accomplished by aquisition of 
series of two dimensional heteronuclear 
experiments. The pulse sequences used herein were 
first introduced by Kay et al. (1989) as a variation 
of the original ‘H”N correlation experiment by 
Bodenhausen & Ruben (1980), with an 
improvement to avoid cross correlation between the 
two relaxation mechanisms, i.e., dipolar coupling 
34 
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and chemical shift anisotropy, proposed by Kay et 
al. (1992). The experiments are designed to avoid 
the insensitivity of the “N nucleus, the 
magnetogyric ratio is about l/l0 of that of ‘H (and 
negative), to prolong the experimental time. 
Refocused INEPT sequences (Morris & Freeman 
1979, Burum & Ernst 1980) use the spin-spin 
coupling to transfer magnetization originating at 
the ‘H to the directly bound “N in the preparation 
period and to return it to ‘H for observation . In the 
t, period, the magnetization is modulated with the 
“N chemical shift. Detection of ‘H therefore 
results in a correlation of the “N and ‘H 
frequencies in the Fourier transformed spectrum. 
For the measurement of relaxation rate constants, 
the relaxation delay in the pulse sequences is 
varied through the series of spectra, resulting in a 
single exponential decaying intensity of each ‘H 
15N crosspeak with a time constant of Ti and T2, 
respectively. In the T2 series the relaxation delay is 
of the Carr-Purcell-Meiboom-Gill (CPMG) type 
(Carr & Purcell, 1954; Meiboom & Gill, 1958). 
The (‘Hi5N) NOE is measured as the ratio of 
signal intensities from spectra recorded in the 
presence and absence of ‘H presaturation, 
respectively. 
The assignments of the “N resonances of 
the two insulin mutants were based on three 
dimensional HMQC-TOCSY (Marion et al., 
1989a, Zuiderweg et al., 1989) and HMQC- 
NOESY spectra (Marion et al., 1989b). These 
experiments are the 3D versions of the original 
TOCSY (Braunschweiler & Ernst, 1983, Bax & 
Davis, 1985) and NOESY (Jeener et al., 1979; 
Anil-Kumar et al., 1980, 1981) experiments. The 
addition of an ‘-% dimension enables the 
correlation of each amide proton to the 
backbonelSN nucleus and overcomes part of the 
problems with overlapping crosspeaks in the 2D 
spectra. The magnetization originates at the 
protons and is modulated by their chemical shift in 
the tl period, the TOCSY or NOESY mixing time 
is followed by a “N chemical shift modulation in 
the tz period, and finally the amide proton 
chemical shifts are observed. Thus, the three 
dimensions of these spectra are, amide protons, “N 
nuclei and all protons. 
The data was recorded on a Bruker 
AMX600. For the 2D experiments 256 tl slices 
consisting of 2048 real data points were sampled 
using the time-proportional phase incrementation 
scheme (TPPI) (Marion & Wiithrich, 1983). With 
16 scans in a tl slice, the experimental time was 
approximately 4 hours for each spectrum. The 
spectral width in the ‘H dimension was 6579 Hz 
and the carrier was placed exactly on the water 
resonance to enable irradiation between the scans. 
In the ‘%I dimension, the spectral width was 1225 
Hz. The 3D experiments were sampled as cubes of 
1024 data points in the t3 dimension, amide 
protons, 64 data points in the t: dimension, ‘-%I 
nuclei, and 256 data points in the ti dimension, all 
protons. 
For the T2 series the following relaxation 
delays were used 9, 17, 34, 43, 56. 69, 77, 90, 98, 
116, 150 and 300 ms. For the T1 series the 
relaxation delays employed were 10, 50, 100, 200, 
300, 400, 500, 700 and 1000 ms. Ti as well as Tz 
were determined as the average of two series. The 
NOE was determined as an average of three pairs 
of spectra. For the INEPT sequences, the delays 
were adjusted to give maximal transfer of 
magnetization, i.e.. (‘/4 x3 ~~~~~~ ). 3 J 
’ H”N 
at a 
value of 92 Hz.. The mixing time of the HMQC- 
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Model Spectral density Input parameters Output parameters 
function 
A J (7) T, ,T2,NOE 9, Te 
B .I (7), RZ=R3+~Ao T, ,T?,NOE S’, G> &s 
C J~F (9) T, ,T:,NOE s,?, ss2, Ts 
D Jred (8) Ti,Tz s’ 
E Ired (8), Rz=Rz+xA,, TI ,Tz S*, Aex 
Table 3.1 Description of the five different models used to fit the generahzed order parameters, S’ or 
S: and S,’ and the correlation times, T, or rs, for the “N-‘H vector motion as well as the exchange 
linebroadening of the “N resonance to the “N relaxation times, T1 and Tz, and the {‘H”N} NOE. 
The spectral density functions listed refer to the text. Each fit was performed minimizing a target 
function, a sum of squared residuals of the parameters involved, i.e., for the models A, B, C 
(~;~~~‘,~~~)’ +( ~;~r~;;h~)’ +( ~~~;~;~~)’ and for the models D, E (‘“;l<;“‘“‘) +( ~~;~L,~““‘)‘. 
NOESY experiment was 120 ms and that of the 
HMQC-TOCSY was 65 ms. 
The processing of the data was performed 
using the processing package MNMR (PRONTO 
Software Development and Distribution, 
Copenhagen, Denmark) or UXNMR (Bruker) on a 
SGI Indigo’. Prior to Fourier Transformation, the 
data was zero filled once in each dimension and a 
gaussian window function ( -7 Hz, factor of 0.15) 
was applied. 
3.2.3 Analysis of the relaxation times, 
Tl and Tz, and the NOE 
Eq 3-5 relate the generalized order 
parameter and the correlation time for internal 
motion to the reciprocal relaxation rates TI, T2 and 
the { ‘H”N}NOE through the spectral density 
function. The spectral density function is defined 
in three different levels in eq 7-9. The first step in 
the analysis is to determine the overall rotational 
correlation time, rr. Under the assumption that the 
overall motion of the protein is the same for all 
residues, the ratio T, /TZ depends only on the 
correlation time for the overall motion, ~~ and is 
constant throughout the molecule (Kay et al., 
1992),. Residues with the line broadened by 
conformational exchange are disregarded. The next 
step is to fit the parameters describing the dynamic 
of each NH-vector to the values measured for T1, 
T2, and NOE through the spectral density function. 
The generalized order parameter, S2, is determined 
for all residues, and in most cases the correlation 
time for internal motion, z,. For some residues a 
linebroadening factor is determined in addition. 
The five different models employed are listed in 
Table 3.1. 
36 
Helle Birk Olsen Insulin Structure 
The first choice of model is A. where all 
available data are fitted simultaneously to a 
generalized order parameter, S’, and a 
corresponding correlation time, re. For a broad 
range of ‘t, values, the NOE is invariant at its 
maximal value and the values of Tr and Tz are 
independent of the correlation time, z,. This 
situation is allowed for in model D. The models B 
or E are used for residues characterized by a small 
T2, i.e., a T, /T, ratio well above the average. Both 
models include a linebroadening term in the T2 
equation. The last model, C, covers motions in two 
different time scales, a fast time scale characterized 
by the order parameter St, on the assumption that 
the corresponding correlation time is < 10 ps, and 
a slower time scale characterized by the order 
parameter Ss2 and the correlation time T,. 
The least squares fits were performed 
using a grid search algorithm programmed in 
Fortran 77. For each residue a grid spanning the 
range of possible values for each parameter was 
searched to determine the global minimum of the 
penalty function. The penalty function for each 
model is listed in the legend to Table 3.1. The 
overall rotational correlation time, rn was kept at a 
constant value in the grid search. The standard 
deviations of the results were calculated as 
described in the supplements section at the end of 
this Chapter. 
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Figure 3.6 Slices from a 3D HMQC-NOESY spectrum (mixing time 150 ms) of the insulin mutant at neutra 
pH. The slices show the intra- and interresidual correlations to the amide proton in the 15N resonance slice o 
each residue. The lines indicate sequential contacts HN-HN and Ha-HN, intra-residual crosspeaks are market 
with * and blue circles surround the helix-characteristic crosspeaks correlating H” of residue i to HN of residue 
i+l NOES. 
3.3 Results 
Analysis of the 3D HMQC-TOCSY and 
HMQC-NOESY spectra gave a straigthforward 
assignment of the “N spectra. Figure 3.6 shows 
‘“N slices from the HMQC-NOESY spectrum of 
the insulin mutant at neutral pH in the helix-region 
BlO-B19. The sequential assignment of residues in 
this region was based on the strong HN-H” con- 
nectivities as well as the weaker Ha-H” con- 
nectivities. The “N chemical shifts are included in 
Table 3.2 at the end of this Chapter. 
The relaxation rate times and the (‘H 
“N }NOE were measured for most residues of the 
two mutants of human insulin. Figure 3.8 depicts 
data from a series of spectra in the T1 measurement 
series of the insulin mutant at neutral pH. Each 
excerpt shows the signals of the residues Bl 1 and 
B12. The intensities were extracted as maximal 
peakheights in an area covering each signal giving 
the single-exponential decaying curves shown in 
Figure 3.7. 
Figure 3.11 gives the complete set of Tr , 
Tz, and NOE measured for the two insulin 
mutants. The numbers are listed in Table 3.2. For 
the mutant at neutral pH the N-terminal residues of 
the B-chain showed cross peaks just above the 
noise level of the spectra making peak intensity 
measurements impossible. 
Figure 3.9 shows the T, /T2 -ratio by 
residue for the two insulin mutants. Note the 
different scales of the two data sets. Marked with 
black are those residues with a ratio falling more 
than one standard deviation outside the average of 
all residues. Above the average are residues with 
38 
Helle Birk Olsen Insulin Structure 
Ggure 3.8 Sections from 12 ‘H-“N 2D spectrl 
n a Tz measurement series marked with tht 
ielay time (ms) used in each experiment. Each 
;ection shows the amide peak from the twc 
.esidues Bll (a) and 812 (b). The contouring 
evels are equidistant starting horn the same 
ower level in all spectra. 
lines broadened by conformational exchange and 
below the average are residues with unusually low 
TI values. 
For the insulin mutant at neutral pH, the 
5, value was calculated from the average of all 
residues excluding the ones marked with black in 
Figure 3.9. Inspection of the data of the insulin 
mutant at acidic pH shows a wider dispersion of 
the T, /Tz -ratio, as a consequence of a larger 
number of residues involved in conformational 
exchange. All of these are excluded from the 
average calculation. The rr values determined for 
the two insulin mutants was 2.86 + 0.21 ns and 
4.98 f 0.49 ns at neutral and acidic pH, 
respectively. 
Figure 3.10 is a graphical representation 
of a grid search using Model A. The area spans S’ 
and rc, and the penalty function (the third 
dimension) involves T,, Tz, and NOE. Obviously, 
Figure 3.7 Peakheights extracted from the T2 
series shown in Figure 3.X. The same arbitrary 
mits are used in the intensity scales of both 
graphs and the noise level is indicated as error 
oars. The lines show the single exponential fit 
employed to extract Tz . Residue Bl 1 is shown 
in panel (a) and residue B12 in panel (b). 
Figure 3.9 The ratio T, /Tz for the two insulin 
mutants. Marked with black are those residues 
for which the ratio falls outside the average by 
more than I standard deviation. 
for this residue the global minimum of S’ is well 
defined in contrast to the global minimum of re. 
The proper choice in this case is Model D, 
corresponding to a one dimensional search in the 
S2 dimension. 
In all attempts to use model C the 
correlation coefftcients between the three 
parameters were = 1 .O, consequently these results 
were discarded. The ratio between DD and CSA 
was approximately O.UO.2 for all residues. 
39 
Helle Birk Olsen Insulin Structure 
Figure 3.8 Sections from 12 ‘H-“N 2D spectrz 
in a T1 measurement series marked with the 
delay time (ms) used in each experiment. Each 
section shows the amide peak from the twc 
residues Bll (a) and 812 (b). The contouring 
levels are equidistant starting from the samt 
lower level in all spectra. 
lines broadened by conformational exchange and 
below the average are residues with unusually low 
T, values. 
For the insulin mutant at neutral pH, the 
rr value was calculated from the average of all 
residues excluding the ones marked with black in 
Figure 3.9. Inspection of the data of the insulin 
mutant at acidic pH shows a wider dispersion of 
the T, /T2 -ratio, as a consequence of a larger 
number of residues involved in conformational 
exchange. All of these are excluded from the 
average calculation. The rr values determined for 
the two insulin mutants was 2.86 f 0.21 ns and 
4.98 f 0.49 ns at neutral and acidic pH, 
respectively. 
Figure 3.10 is a graphical representation 
of a grid search using Model A. The area spans S’ 
and rc and the penalty function (the third 
dimension) involves T,, Tz, and NOE. Obviously, 
Figure 3.7 Peakheights extracted from the T: 
;eries shown in Figure 3.8. The same arbitrary 
Anits are used in the intensity scales of both 
graphs and the noise level is indicated as error 
)ars. The lines show the single exponential fil 
:mployed to extract Tz . Residue Bl 1 is showr 
.n panel (a) and residue B12 in panel (b). 
Figure 3.9 The ratio T, /Tz for the two insulin 
nutants. Marked with black are those residues 
‘or which the ratio falls outside the average by 
nore than 1 standard deviation. 
for this residue the global minimum of S’ is well 
defined in contrast to the global minimum of c,. 
The proper choice in this case is Model D, 
corresponding to a one dimensional search in the 
S* dimension. 
In all attempts to use model C the 
correlation coefficients between the three 
parameters were = 1 .O, consequently these results 
were discarded. The ratio between DD and CSA 
was approximately O.WO.2 for all residues. 
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Figure 3.11 “N relaxation parameters, T, and Tz measured in seconds, and ‘H”N NOE for twc 
insulin mutants. The relaxation times are measured in seconds. The left-hand side panel shows tht 
insulin mutant at acidic pH, and the right-hand side panel shows the insulin mutant at neutral pH. 
The results of the fit covering two 
different time scales are tabulated in Table 3.3. 
Figure 3.12 depicts the picosecond dynamics 
represented by the generalized order parameter 
together with the rms deviations of the backbone of 
an ensemble of structures. The eye is immediately 
caught by the tine accordance between the the two 
mappings. 
For the B-chain residues the picoseconds 
dynamics in the termini are retlected in the 
precision of the calculated structures. Moreover, 
the decline of the curves in the loop regions 
flanking the central B-helix, B19-B22 and B7-B9, 
is a common trend. The overall level of the order 
parameters for the mutant at neutral pH is below 
that of the mutant at acidic pH, the same thing 
goes for an comparison of the rms deviations of the 
two mutants. The B-chain helix shows a region of 
higher mobility around residue BI 5, which is not 
reflected in rms deviations. 
The two A-chain helices share the same 
characteristics, i.e, higher mobility in the termini 
than in the middle of the helix. The loop region is 
Ggure 3.10 Section of a S’ ,rC surface 
panning the global minimum area. The 
,ertical axis shows the penalty function. The 
lata represents the fit of T,, T1, and NOE for 
‘N in residue Al5 of the insulin mutant al 
neutral pH using model A. 
more mobile than the helices. The most striking 
difference between the two mutants is the overall 
stability of the helices. For both mutants the order 
parameter level of the A(II)-helix and the B-helix 
is similar. However, the mobility of these helices 
compared to the A(I)-helix is not the same. At 
acidic pH, the A(I)-helix shows higher mobility 
whereas at neutral pH the mobility of the A(I)- 
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Figure 3.12 Dynamics in the picoseconds time 
scale and precision of the three dimensional 
structure. General order parameter for internal 
motion of the NH-vectors (top) and rms of the 
backbone (bottom). Data from two insulin mutants 
is shown, BIG His, des-B30 mutant at acidic pH 
(red) and (B I, Bl 0, B16, B27) Glu, des-B30 
mutant at neutral pH (green). 
helix is lower. As was the case for residue Bl5, the 
region around residue Al 5 also shows 
unexpectedly high mobility (when comparing to 
the rms). 
The millisecond dynamics represented by 
broadening of the “N resonances (Figure 3.13) 
show resemblances between the two pH values in 
the A(I)-helix and in the A-chain loop region both 
of which are characterized by linebroadenings. At 
acidic pH, additional linebroadenings are scattered 
throughout the structure. 
Figure 3.13 Dynamics in the milliseconds time 
;cale. Linebroadening of the 15N resonana 
:aused by conformational exchange. Data fron 
IWO insulin mutants is shown, B16 His, des-B3( 
nutant at acidic pH (red) and (Bl, BlO, B16 
B27) Glu, des-B30 mutant at neutral pF 
green). 
3.4 Discussion 
The relaxation properties of the 15N nuclei 
in the backbone of two mutants of human insulin 
B16 His, des-B30 and (Bl, BlO, B16, B27) Glu, 
des-B30 in aqueous solution have been under 
investigation. The biological activity of the mutants 
is 43 % and 47 %, respectively. These two mutants 
have been engineered to overcome complications 
resulting from aggregation of insulin molecules in 
different pH regions. Thus the (Bl, B 10, B16, B27) 
Glu mutant was investigated at near neutral pH 6.5 
(34”(Z), and the B16 His mutant at acidic pH 2.5 
(24°C). The three dimensional structures of the 
mutants have been determined prior to this 
investigation (Ludvigsen et al., 1994, and Chapter 
2). The structures show slight differences mostly 
confined to the termini of the B-chain. These 
differences arise due to the insertion of the charged 
Glu sidechains in the (Bl,BlO,B16,B27) Glu, des- 
B30 mutant and are therefore only indirectly an 
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effect caused by a change in pH. The difference of 
overall precision between the two structures are 
more pronounced. The aim of the analysis of the 
“N relaxation properties of the two insulin mutants 
has been to map the backbone dynamics at 
different solution acidity and to examine the 
relation to the overall precision of the calculated 
structures. 
The first result was the determination of 
the correlation time, ‘I~, of the overall tumbling of 
the protein. Stokes law relates the frictional 
constant, f, to the effective radius of the protein, 
reff, through f=6IIr,tfll, where n is the viscosity of 
the solvent. ~~ is proportional to f and therefore 
dependent on the effective radius of the protein as 
well as on the viscosity of the solvent. r, for the two 
insulin mutants at neutral pH, 24°C and acidic pH, 
34’C was surprisingly different, 2.86 + 0.21 ns and 
4.98 + 0.48 ns, respectively. Part of the difference 
of rr is caused by the different temperatures 
employed. The viscosity of the solvent (water) at 
the two temperatures employed here are 
~~~~=0.91 lcp and ~~~c=O.7340 cp (Hand-book of 
Chemistry and Physics, Chemical Rubber 
Company). With offset in ~~ measured for the 
insulin mutant at neutral pH, 34°C ~~ for the 
mutant at acidic pH corrected to the same 
temperature takes a value of approximately 3.55 
ns. The pH of the solvent influences the viscosity 
although this contribution is minor. Upon 
dissolution of the lyophilized insulin mutant in 
water to a concentration of 2.5 mM the difference 
in addition of HCl required to adjust the pH to 2.5 
and 6.5, respectively, is approximately 15 mM. 
The effect of this is a slightly increased viscosity of 
the solvent in the acidic solution, < 1 % (Handbook 
of Chemistry and Physics, Chemical Rubber 
Company). Thus the difference in viscosity of the 
solvent of the two investigations can not explain all 
of the difference between the measured rr values. 
The attention is therefore concentrated on the 
effective radii of the two insulin mutants. 
Apparently ref of the acidic pH mutant is larger 
than r,ff of the neutral pH mutant. As mentioned 
above, the structural studies revealed only small 
differences in the three dimensional structure of 
the two mutants. The most prominent difference is 
the poorly defined termini of the B-chain of the 
mutant observed at neutral pH (Figure 3.15), which 
qualitatively preserves or even increaces the radius 
of this mutant. The net relative charge of the two 
mutants is the same but oppositely signed (-5.5 at 
neutral pH and +6 at acidic pH), and the 
distribution of the charges in the three dimensional 
space are almost identical, but the effect of the 
different ionic strengths of the solutions on the 
hydrodynamic volume of the two mutants is not 
straightforward to account for. Thus, from NMR 
data alone, it is not possible to explain the different 
correlation times measured here. 
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Figure 3.14 Average three dimensional structures of the two insulin mutants at acidic pH (a) ant 
neutral pH (b). The structures are colored according to the conformational exchange linebroadening o 
the “N resonance. 
As was shown in Figure 3.13 the two 
insulin mutants show different patterns in the 
linebroadening of the “N resonances. At both pH 
values the A(I)-helix, and especially the A5 and 
the A6 residues as well as part of the loop region 
connecting the two helices in the A-chain show 
millisecond time scale dynamics. Figure 3.14 
shows the line-broadening data as colorcodes for 
the three dimensional structures. Focusing on the 
neutral pH structure the linebroadenings are 
obviously located in the distinct three dimensional 
area surrounding the inter-chain disultide bridge 
A7-B7 and the intra-chain disulfide bridge A6- 
Al 1. The origin of these linebroadenings is 
therefore proposed to be disultide bond 
isomerizations taking place in the millisecond to 
second time scale (see e.g. Otting et al., 1993) thus 
giving rise to broadening of the ‘“N resonance 
lines. The ‘H resonance lines in the same areas are 
broadened as well (Ludvigsen et al., 1994). At 
acidic pH, the A-chain dynamics propagate to the 
well defined part of the N-terminus of the B-chain 
which is close in space at this pH. Apparently, the 
milliseconds time scale dynamic is more 
pronounced at acidic pH and furthermore all 
secondary structural elements of the molecule are 
involved. The fact that the residues exhibiting 
dynamics in the milliseconds regime are not 
concentrated near the mutation sites but scattered 
throughout the structure implies that this 
phenomenon is intrinsic to the pH (or the 
temperature). 
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Figure 3.15 Average three dimensional structures of the two insulin mutants colored according to the 
rms of the backbone (top), and the order parameters for the picoseconds dynamics (bottom). (a) is the 
insulin mutant at acidic pH and (b) is the insulin mutant at neutral pH. 
With references to Figure 3.12 and to the 
alternative view in Figure 3.15, the accordance 
between the generalized order parameter and the 
rms is striking for almost all residues at both pH 
values. Furthermore, the difference of overall 
precision between the two structures is mirrored 
perfectly in the overall levels of the generalized 
order parameter. Obviously picoseconds regime 
dynamics are responsible for the quenching of 
NOES in the termini of the B-chain, as it is 
reflected in the increased rms deviations in these 
areas. The more pronounced detachment of the 
termini from the core of the molecule at neutral 
pH, caused by introduction of the charged 
glutamate residues (see Chapter 2), is reflected 
perfectly in the decline of the order parameter in 
these regions. The characteristic shape of the order 
parameter plot in the A-chain helices suggests the 
nature of the motions in these regions to be a bend 
of the helix (Pervushin et al., 1995). The 
dispersion of order parameter levels between the 
three helices are, however, not identical in the two 
investigations. The B-chain helix and the A(II)- 
helix share a common level in both investigation. 
Compared to this level, the A(I)-helix is relatively 
more mobile at acidic pH than at neutral pH. The 
importance of the A(I)-helix as to biological 
activity ( examined in Chapter 4) makes this result 
worth noting. 
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3.5 Supplements 
Standard deviation calculation, model A 
Given are two relaxation rate times, Tr and Tz, with standard 
deviations 0 7., and 0 7: and the NOE with standard deviation 
CT ,kVh’o,l . From these tigures the two parameters S’, the gcncralized 
order parameter, and s,, the correlation time for internal movement, 
are calculated. 
(11) 
The variance matrix of the relaxation rate constants and the NOE 
contains the squared standard deviations of the three parameters on 
the diagonal, the off diagonal elements contain the correlations 
between the parameters. Assuming no correlation between the 
relaxation rate constants and the NOE the variance matrix is 
The variance matrix of the resulting SZ and ‘I, is calculated from 
var(~;) = D-~ar(~;j -D’ (13) 
where D is 
(,4) 
and D is the transposed D matrix. The D matrix elements are 
determined by numerical dikrentiation. 
The elements in the resulting variance matrix for S’ and rC are 
given by 
I I 
the diagonal elements are the squared standard deviations of S’ and 
L., and the off-diagonal elements are correlations between the 
corresponding diagonal elements. 
I I 
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Table 3.2 lSN relaxation data TI , TP, and NOE and “N chemical shift measured in ppm relative to the external 
reference 22.7 % NH3 in aqueous solution. 
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Table 3.3 Generalized order parameters and exchange line broadening 
Insulin Structure 
02” 
821 
822 
1 0.G 1 0.04 1 I I 
I Ioool OX6 I I I I I I 
1 0.91 1 ““5 1 I 1 0.79 1 I 
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4. Investigating structure function 
relationship of the A(I)-helix 
This section presents the preliminary 
assignments of the NMR spectra of two mutants of 
human insulin. Both mutants are engineered in 
continuation of the (Bl, BlO, B16, B27) Glu, des- 
B30 mutant adding a point mutation in the A(l)- 
helix in order to enhance or diminish, respectively, 
the biological activity. The A3 Gly, (Bl , BlO, B16, 
B27) Glu, des-B30 mutant shows a biological 
activity of 0.1 % and the A8 His, (Bl, BlO, B16, 
B27) Glu, des-B30 mutant exhibits 143 % 
biological activity relative to the native species. 
The assignment of spin systems has been 
accomplished using DQF-COSY and TOCSY 
spectra. The NOESY spectra have been assigned to 
the point of sequential arrangement of the spin 
systems and secondary structure and compared to 
the (Bl, BlO, B16, B27) Glu, des-B30 NOESY 
spectrum on selected NOES indicative of the 
tertiary fold of the molecule. 
4.1 The A(I)-helix region 
Throughout all determinations of insulin 
structures by NMR so far (see references in Table 
2.3) the A2-A8 region takes a helical 
conformation. This is in agreement with the 
structures known from crystals. Although the 
structural definition of this region is poor, 
compared to the B-chain-helix (B9-B19) and the 
A(E)-helix (Al2-Al9), the helix propensity is 
clear. The Al Gly, A2 Ile, and the two Cys 
residues A6 and A7 are invariant in naturally 
occuring insulins. The Cys residues are involved in 
two disulfide bridges, the A6-All intrachain- and 
the A7-B7 interchain-connection. The backbone 
dynamics in the millisecond timescale of the (Bl, 
BlO, B16, B27) Glu, des-B30 mutant (Chapter 
concentrate in the three dimensional region 
these disultide bridges. This is interpreted as 
indication of disulfide bond isomerization. 
3) 
of 
an 
The A-chain N-terminus is part of one of the 
putative receptor binding sites of insulin (Pullen et 
al., 1976). This is evidenced by the marked 
influence of mutations and deletions in this region 
on the biological activity of the species. The 
relationship of specific sidechain conformations in 
the region to the biological activity has not been 
completely mapped. In the systematic approach, 
‘Ala-scan’, each residue in turn is mutated by 
Alanin. Replacement of a residue by Ala 
corresponds to a deletion of the sidechain causing 
minimal disruption of the backbone conformation. 
This is in contrast to the backbone flexibility 
imposed by a Gly replacement. Part of this ‘-Ala- 
scan’ can be pieced together from various 
publications. Compared to native insulin. the 
biological activities of the mutants with Ala point 
mutations are : Al Gly + Ala 9 % (Cosmatos et 
al., 1978), A2 Ile + Ala 0.6 %, A3 Val + Ala 1.8 
% (Nakagawa & Tager, 1992), A5 Gln -+ Ala 49 
% (Ma&i et al., 1979), the double substitution of 
A6 Cys and Al 1 Cys by Ala 8 % (Marki et al., 
1979), and finally A8 Thr + Ala 112 % 
(Kaarsholm et al., 1993). In addition to this, 
several publications present mutations in the .4(I)- 
helix region with other amino acids as 
summareized here. In position Al, mutations \\ith 
D-amino acids gives a slight reduction or a 
retention of the biological activity, this is in 
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contrast to mutations with the same amino acids in 
the naturally occurring L conformation, which 
causes IO-100 fold reduction (Cosmatos et al., 
1978, Geiger at al., 1980 and 1982). In position 
A2, the mutation Ile -+ Val has only little effect on 
biological activity, whereas any other mutation 
causes a IO-100 fold reduction. In position A3, the 
biological activity is reduced by 100-1000, 
regardless of the mutation applied (Nakagawa & 
Tager, 1992). Furthermore, deletion of Al, Al-A2, 
Al-A3 (Nakagawa & Tager, 1992), or Al-A4 
(Ferderigos et al., 1983) reduces the biological 
activity to < 0.003 % compared to the native 
species. In position A5 a substitution with Leu 
gives 30 % biological activity (Ferderigos et al., 
1983). Introduction of the D form of Cys in 
positions A6 and A7 causes a reduction of 
biological activity to < 0.002 %. In contrast to 
these reductions, an increased biological activity is 
obtained by a stabilization of the A(I)-helix (as 
well as the B-chain helix, e.g. BlO Glu) 
(Kaarsholm et al., 1993). The introduction of the 
positively charged His or Arg residues to replace 
the Thr in position A8, the C cap of the helix, i.e. 
the negatively charged end of the helix-dipole, 
causes a 3 fold increase in bioactivity in concert 
with an enhancement of the folding stability. Note 
also that, ‘miniproinsulin’, i.e., insulin with a 
peptide crosslink between the termini of the two 
chains, B29 Lys to Al Gly, shows a 1000 fold 
decrease of receptor binding potency (Markussen et 
al., 1985). The structure of ‘miniproinsulin’ is 
close to the structure of the native species, only 
slightly more compact (Derewenda et al., 1991). 
As summarized above the biological activity of 
insulin is highly sensitive to mutations in the N- 
terminal A-chain helix. Substitutions of residues in 
the A2-A7 region cause a reduction of the 
biological activity, most of them even a dramatic 
reduction. In contrast, the introduction of His or 
Arg in the C cap of the helix, residue A8, increases 
the biological activity to approximately 300 % 
compared to the native species. 
The relationship between the effect on 
biological activity and the perturbations of the 
three dimensional structure imposed by these 
mutations is, however, not examined in detail. An 
investigation of two insulin mutants with reduced. 
A3 Val -+ Gly, and increased, A8 Thr + His. 
biological activity has been initiated to adress this 
issue. In continuation of the (Bl, BlO, B16, B27) 
Glu, des-B30 mutant (biological activity 43 %). of 
which the structure is determined at physiological 
pH (Chapter 2) , the point mutations have been 
added to this species giving biological activities of 
143 % for the A8 His, (Bl, BlO, B16, B27) Glu. 
des-B30 mutant (+A8 His) and 0.1 % for the A3 
Gly, (Bl, BlO, B16, B27) Glu, des-B30 mutant 
(+A3 Gly) respectively. 
4.2 Materials and methods 
The two insulin mutants, ‘A8 His and -.A3 
Gly, were constructed, fermented and purified as 
desribed for the (Bl,BlO.B16,B27) Glu, des-B30 
mutant in Chapter 2. The experimental conditions 
were duplicated, i.e., the samples were prepared at 
a concentration of 2.5 mM in lo/90 DlOiHzO and 
pH was adjusted to a direct meter reading of 6.5. 
All NMR experiments were recorded at a 
temperature of 307 K. The series of NMR 
experiments recorded were similar to the series for 
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the (Bl,BlO,B16,B27) Glu, des-B30 mutant, refer 
to Chapter 2 for the details. 
4.3 Results 
The 1D ‘H spectra of the three insulin 
mutants (Bl,BlO,B16,B27) Glu, des-B30 (basis), 
‘A3 Gly and ‘A8 His are shown in Figure 4.1. The 
monomeric character of the ‘A3 Gly and ‘A8 His 
species is evident from the high resolution of the 
spectra, which is comparable to the resolution of 
the basis mutant spectrum. 
The near-UV CD spectrum of the basis 
mutant at increasing protein concentration was 
shown in Figure 2.4. The spectra of the +A3 Gly 
and ‘A8 His mutants (not shown) share the same 
characteristics, i.e., independence of protein con- 
centration. This is a further evidence of the mono- 
meric character of both mutants. 
Figure 4.2 gives an impression of the fine 
quality of the DQF-COSY and NOESY spectra of 
both mutants. Both set of spectra are in close 
resemblance to the spectra of the basis mutant 
(Figure 2.5). This applies to the dispersion as well 
as the linewidths of the crosspeaks in the 
fingerprint region of the DQF-COSY spectra. The 
similarities are even more clear in the excerpts 
from the NOESY spectra. Apparently the effect of 
the mutations on the amide proton resonances in 
the B-chain helix and the A(II)-helix are minor. 
The dispersion of the resonances in the fingerprint 
region of the DQF-COSY spectra made the 
assignment of the spectra, using the method of 
Wtithrich (1986), fairly straightforward. The major 
part of the HNP crosspeaks were assigned in the 
DQF-COSY spectra, and annotated on the plot. 
The TOCSY spectra allowed the assignment of the 
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basis 
I”“I”“I”“I”“I”“1~“‘1”“,““I 
9.5 9.0 8.5 8.0 1.5 6.5 ppm 
l““,““,““l”“,““I““I”“,““I 
9.5 9.0 8.5 8.0 7.3 7.0 6.5 ppm 
+A8 His IL 
I”“I”“I’ “I”“I”“l”“I”~‘I”“I 
9.5 9.0 8.5 8.0 7.5 7.0 6.5 ppm 
Figure 4.1 1D proton spectra of three insulin 
nutants, region of amide and aromatic protons. 
rest. but still the N-terminal residues of both 
chains, Al Gly and Bl Glu, as well as B8 Gly are 
unassigned. For the +A8 His mutant the A9 Ser 
misses assignment as well. During the sequential 
analysis the major part of the B-chain, B2-B7 and 
B9-B29, and the A-chain stretches A2-A8 and 
A 1 O-A2 1 was assigned. Table 4.1 at the end of this 
chapter lists the chemical shifts of both mutants. 
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Figure 4.2 Sections from DQF-COSY spectra (top) and NOESY spectra (mixingtime 120 ms) 
Ibottom). In the fingerprint region of the DQF COSY spectrum the major part of the identified 
:orrelations between a-protons and amide protons is annotated. The correlations between amide 
wotons of neighboring residues, indicative of helical areas in the structure, are annotated in the bottom 
panel and lines are drawn to follow the amide protons throughout the helices. 
Part of the secondary structural elements Thr + His mutation in the helix C cap. Note that 
of the mutants, the helix regions, are indicated in 
the excerpts from the NOESY spectra in the 
bottom panel of Figure 4.2. Intense H”HN 
connectivities are assigned for both mutants in the 
B-chain helix region, BlO-B20, and in the A(II)- 
helix region, A14-A20. In contrast to the +A3 Gly 
mutant (and the basis, Figure 2.4) the spectrum of 
the +A8 His mutant shows intense HNHN 
connectivities in the A(I)-helix, A3-A7. This is an 
evidence of the helix stabilization caused by the A8 
the basis mutant spectra do show HNH” con- 
nectivities in the A3-A5 region, these peaks are 
less intense and visible, but not annotated, in 
Figure 2.5. 
Further indications of secondary structure 
come from comparison of the a-proton chemical 
shift and the random coil values. the secondary 
chemical shifts of the a-protons. Data for all three 
mutants is shown in the left-hand column of Figure 
4.3. The helix elements predicted by the extents of 
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0.x 
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- 0.4 
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-0.8 ‘, : , , I .I, \--I -0.x 
Al A5 ,A10 Al5 A20 85 I310 815 BZO I325 829 Al A5 AIO Al5 A20 US BIO Bl5 I320 B25 829 
Tigure 4.3 Secondary chemical shifts of the cx-protons for three insulin mutants. The left hand column 
:ontains the difference by residue between the measured chemical shift and the random coil value 
Cegions predicted to be helix from these data are marked with lines. The right hand column contain 
he differences between the measured chemical shifts of the -‘A3 Gly and ‘A8 His mutants and those o 
he basis mutant, the points of mutation are left out. 
secondary chemical shifts (Wishart et al., 1992) are 
annotated in the plots. The B-chain and the A(II)- 
helix regions are predicted for all three mutants, 
and the differences between the three mutants in 
these regions are only minor. 
The N-terminal region of the A-chain, 
however, shows marked differences among the 
mutants. The size of the upfield shifts of the A3, 
A4, A5 cx protons of the ‘A8 His mutant compared 
to the basis mutant indicate the A(1) helix to be 
better defined in the ‘A8 His mutant. The ‘A3 Gly 
mutant, on the other hand shows no sign of helix 
content in this region. These predictions are in 
agreement with the observation of intense HNHN 
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Figure 4.4 Perturbation of the three dimensional structure caused by point mutations. The structure 
of the basis mutant is color coded according to difference in a-proton chemical shifts between the two 
mutants ‘A3 Gly and ‘A8 His and the basis mutant. 
connectivities in the A3-A7 region of the +A8 His 
mutant, and the absence of the same connectivities 
in the specctra of the basis and the +A3 Gly 
mutants. 
The right-hand column of Figure 4.3 
shows another secondary chemical shift, the 
difference in chemical shift of the +A3 Gly and +A8 
His a-protons, respectively, and the basis mutant 
a-protons. The experimental conditions, i.e., 
temperature, pH, and protein concentration, of the 
three investigations is the same, i.e., the major 
influence on this secondary chemical shift comes 
from differences in the secondary and tertiary 
structure caused by the point mutations. 
For the ‘A3 Gly mutant, secondary 
chemical shifts are observed throughout the A2- 
Al0 region. In addition to this, the loop region of 
the B-chain, which is connected to A-chain N- 
terminal region by the A7-B7 disulfide bridge, as 
well as the A19 residue show secondary chemical 
shifts. The C-terminus of the B-chain is 
characterized by secondary chemical shifts 
increasing towards the end. 
The extent of secondary chemical shifts in 
the “A8 His mutant is less than in the +A3 Gly 
mutant. The primary structure around the point 
mutation is affected, the shift of the A3 and A4 
protons can be subscribed to the strengthening of 
the helix. The spatially close B-chain residues, B5- 
BlO, are affected, as was the case for the +A3 Gly 
mutant. The secondary chemical shifts in the C- 
terminus of the B-chain are negligible. 
The close similarity between the spectra of 
the three mutants and the identical A(B) and B- 
chain helix regions as well suggest the three 
dimensional structure of the core of the molecule to 
be conserved throughout. In order to confirm these 
observations, a few preliminary assignments of 
NOES, based on NOES found in the spectra of the 
basis mutant, has been accomplished in the spectra 
of both mutants. The internal arrangement of the 
A-chain elements are substantiated by NOES from 
the sidechain of residue Ile A2 to the aromatic part 
of residue Tyr A19. NOES from the sidechain of 
Leu B15 to the aromatic part of Phe B24 indicate 
the conservation of the antiparallel helix-strand 
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motif in the B-chain. Finally, NOES from the 
sidechain of Leu B15 to the aromatic part of Tyr 
Al9 as well as from the sidechain of Ile Al0 to the 
sidechains of the Asn B3, Gln B4, and His B5 
residues confirm the conservation of the mutual 
arrangement of the chains. 
4.4 Conclusion 
In continuation of the (Bl ,B 10,B 16,B27) 
Glu, des-B30 insulin mutant of which the three 
dimensional structure is known, two mutants 
employing point mutations in the A(I)-helix has 
been engineered. The A(l)-helix is part of one of 
the putative receptor binding sites of insulin, and 
the aim of the mutations has been to manipulate 
the biological activity. The NMR spectra of these 
two insulin mutants A3 Gly, (Bl,BlO,Bl6,B27) 
Glu, des-B30 (biological activity of 0.1 %) and A8 
His, (B 1 ,B lO,Bl6,B27) Glu, des-B30 (biological 
activity of 143 %) has been examined as to the 
sequential assignment of spinsystems and 
secondary structure. The helix regions in the B- 
chain (B9-B19) and in the C-terminus of the A- 
chain (A13-A19) is conserved as evidenced by 
close contacts between neighboring amide proton. 
The chemical shift of the a-protons compared to 
random coil values give indications of the B-chain 
and A(B)-helices. Furthermore a lack of helix 
structure in the A2-A8 region of the ‘A3 Gly 
mutant and a strengthening of the helix in the 
same region (the A(I)-helix) in the ‘A8 His mutant 
is evidenced by these secondary chemical shifts. A 
few NOES indicative of the tertiary fold of the 
molecule assigned for the basis mutant have been 
found in the spectra of both mutants. These 
assignments indicate a conservation of the overall 
spatial arrangement of the secondary structural 
elements in both chains as well as the mutual 
arrangement of the chains. A comparison of the 
chemical shift of the a-protons of the hvo mutants 
to those of the basis mutant gives a direct measure 
of the propagation of the structural changes caused 
by the point mutations. The conformational 
changes of the +A8 His mutant is confined to the 
A(I)-helix especially residues A3 and A4, as a 
consequence of the stabilized helix, and the 
spatially close B-chain loop area. The apparent 
unravelling of the A(I)-helix of the +A3 Gly 
mutant affects the B-chain loop area as well and 
furthermore to the C terminus of the B-chain. 
The complete assignment of the NOESY 
spectra of the two mutants as a prerequisite of the 
structure determination will add details to the 
observations listed above. The precise structure of 
the backbone and indeed the presentation of 
sidechains in the A(I)-helix region will be 
important results in the examination of the 
relationship between structure and biological 
activity of insulin. Moreover, measurements of the 
relaxation parameters of the backbone “N nuclei 
will allow a detailed description of the millisecond 
and picosecond dynamics of the backbone of the 
mutants in comparison to the basis mutant. 
- 
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rable 4.1 ‘H chemical shifts of the +A3 Gly and +A8 His insulin mutants. 
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5. Conclusion 
This Chapter gives a summary of the results described in the preceeding Chapters as well as 
the concluding remarks of the present thesis. 
The three dimensional structure of the (Bl, BlO, B16, B27) Glu, des -B30 mutant of human 
insulin in aqueous solution at neutral pH was determined by ‘H two-dimensional NMR. The 
aggregation problems that characterize millimolar solutions of the native species are succesfully 
overcome by site-directed mutagenesis of the dimer- and hexamer-forming surfaces with only minor 
effect of the biological activity (47 O/o compared to that of native insulin). The insulin mutant is 
monomeric in the neutral pH range, and the three dimensional structure is the first insulin structure 
determined at physiological pH. The core of the molecule is structurally well-defined with an rms 
between the 25 calculated structures and their average of 0.66 A for the backbone atoms (A2-A19, 
B4-B26). The A-chain consists of the antiparallel helices A2-A8 and Al2-Al9 connected by a loop, 
the B-chain residues Bl-B4 are disordered, residues B5-B8 are in a loop region flanking the central 
B-chain helix that comprises residues B9-B19, residues B20-B23 forms a type I turn continuing in the 
N-terminal strand, B27-B29 are disordered. The disorder in the B-chain termini is subscribed to the 
insertion of the charged Glu sidechains. The structure of this insulin mutant was compared to the 
structures of other monomeric insulin mutants determined at acidic pH. Apart from the differences in 
overall precision of the structures a common feature is the spatial arrangement of the well defined part 
of the structure, the core of the molecule, comprising the A-chain and the central B-chain helix, 
backbone as well as sidechains. The (Bl, BlO, B16, B27) Glu, des-B30 showed closest structural 
resemblance to the B16 His mutant, the best defined structure in the set, rms of the backbone for this 
mutant is 0.46 8, in the region A2-A19, B4-B28. 
In order to elucidate the inherent dynamics of the (Bl, BlO, B16, B27) Glu, des-B30 mutant 
of human insulin at neutral pH as compared to the dynamics of the B 16 His, des-B30 mutant of which 
the three dimensional strucuture has been determined at acidic pH, the backbone dynamics of the “N 
enriched mutants were examined. The relaxation parameters, T,, Tl, and NOE of the amide “N 
nuclei, are translated to a generalized order parameter, S2, describing the spatial restriction of each 
NH-vector. A fine overall coherence between the rms and the spatial restriction of the NH-vector 
motion of each residue is observed for both mutants. This points to the pica-nanoseconds timescale 
motions to be responsible for the lack of NOES in the termini of both chains that leads to disorder in 
the calculated structures. Moreover the difference in rms levels between the two mutants is reflected 
in a similar difference in NH-vector motion level. The millisecond time scale motions observed in the 
spatial surroundings of the two disultide bridges A6-All and A7-B7 at neutral pH are interpreted as 
evidence for disultide bond isomerization. The millisecond time scale motions at acidic pH are more 
pronounced and involves all secondary structural elements. 
The preliminary assignments of the NMR spectra of the two insulin mutants A3 Gly, (Bl, 
BlO, B16, B27) Glu, des-B30 and A8 His, (Bl, BlO, B16, B27) Glu, des-B30 with biological 
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activities of 0.1 % and 143 % respectively, compared to native insulin lead to conclusions concerning 
the secondary and tertiary structure of these mutants. The immediate resemblance of these spectra to 
the spectra of the (Bl, BlO, B16, B27) Glu, des-B30 mutant indicates the overall three dimensional 
structure to be conserved, this is confirmed by the assignment of a subset of the NOES indicative of 
the tertiary structure. The sequential assignment and the cc-proton chemical shifts as compared to 
their random coil values and to the chemical shift of the (Bl, B 10, B16, B27) Glu, des B30 mutant cx- 
protons revealed similarities as well as differences. The helix in the A2-A8 region of the A8 His, (B1, 
BlO, B16, B27) Glu, des-B30 is strengthened, this change in conformation propagates (through the 
disulfide bridges) to the spatially close B-chain loop region especially B9 and to the residues Al 1 and 
A12. In the A3 Gly, (Bl, BlO, B16, B27) Glu, des-B30 mutant the helix propensity of the A2-A8 
region is lost, the structural disorder spreads to the same regions as for the other mutant, but also to 
the N-terminal part of the B-chain and to some extent to the B-chain helix. 
The determination of the three dimensional structure of the (Bl , B 10, B 16, B27) Glu, des- 
B30 mutant at physiological pH and the knowledge of the inherent dynamics provides the basis for 
future investigations of the relationship between structure and biological activity of insulin species. 
The detailed structure determination of the two mutants with manipulated biological activity of which 
the preliminary assignments have already revealed local changes in secondary structure and located 
the regions of structural perturbations, will undoubtedly lead to a closer insight into this complicated 
area. Furthermore, if the future brings fragments of the soluble parts of the insulin receptor that bind 
the insulin molecule, of size and properties suitable for binding studies by NMR, the (B 1, B 10, B 16, 
B27) Glu, des-B30 mutant will be an obvious candidate to be used in this context. 
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6. Danish summary / Dansk sammenfatning 
Nzrvazrende ph.d. afhandling omhandler NMR (kerne magnetisk resonans) spektroskopiske 
undersogelser af struktur og dynamik af en raekke mutanter af human insulin. Projektet blev udfort 
som en erhvervsforskeruddannelse i et samarbejde mellem Novo Nordisk A/S, Roskilde Univer- 
sitetscenter og Akademiet for de Teknisk Videnskaber (ATV). 
Den insulinkrzvende (Type 1) diabetes mellitus er karakteriseret ved en starkt nedsat eller 
fravaerende produktion af endogen insulin. Patienter med denne kroniske sygdom behandles med 
subkutane injektioner af insulinprazparater en eller flere gange dagligt for at opretholde et nogenlunde 
normalt blodsukkerniveau. Pa Novo Nordisk forskes til stadighed i at udvikle denne injektionsterapi 
til sB pracist som muligt at efterligne kroppens normale insulinprofil. Et meget attraktiti langsigtet 
rnil er at udvikle et insulinmimetika, som kan indgives peroralt. Derfor er der i de seneste ar udfert 
forskning med henblik pa at karakterisere bindingsomriderne pa insulinreceptoren. Paralielt hermed 
serges ammenhamgen mellem forskellige insulin mutanters variable affinitet for insulinreceptoren og 
deres tre-dimensionelle struktur klarlagt, her-under borer undersogelse af de strukturandringer som 
folger af insulins binding til receptoren. Dette projekt er ivserksat som en de1 af denne klarhegning. 
Insulin besdr af 51 aminosyre rester fordelt pi to kaeder, A-kaden best& af 21 rester og B- 
kaden bestir af 30 rester. De to kazder er indbyrdes forbundet af to svovlbroer, A7-B7 og A20-B19. 
herudover tindes en svovlbro internt i A-kaeden, A6-All. Den rumlige struktur af insulin molekylet er 
grundigt undersogt vha. Rontgen-krystallografi. I naerwer af zinc krystalliserer molekylet i hexamer- 
aggregater sammensat af tre ens dimerer. Den biologisk aktive konformation af insulin er imidlertid 
monomeren. 
En razkke komplicerede aggregerings- og oploseligheds-forhold vanskeliggor detaljerede 
strukturstudier vha. NMR spektroskopi af den native monomer i det fysiologiske pH omride. Ved at 
indfore substitutioner af aminosyre rester i begge aggregeringsflader har det imidlertid vist sig muligt 
at fremstille en mutant af human insulin, som er monomer netop i det onskede pH omrbde. Den 
biologiske aktivitet af mutanten er 47 % af den oprindelige. Den tre-dimensionelle struktur af (Bl. 
BlO, B16, B27) Glu, des-B30 mutanten blev bestemt ved pH 6.5. Strukturen er generelt veldefineret. 
rms (root mean square) for backbone i omrbdeme A2-A19 og B4-B26 er 0.66 A. Strukturen i 
oplosning adskiller sig kun lidt fra krystalstruktureme. A-kreden betdr af to antiparallelle helix 
omrader, A(I)-helixen, A2-A8, og A(II)-helixen, A12-A19, forbundet af et loop. I B-kaden er Bl-B3 
uordnede, B4-B8 danner et loop til den centrale a-helix, B9-B19, herefter ses et type I turn, B20-B23. 
som fortsatter i en P-struktur, resterne B27-B29 er uordnede. Falles for denne struktur og strukturen 
af andre insulin mutanter bestemt i sur oplssning, er et veldefineret kemeomrade. som bestir af B- 
kade helixen og hele A-kaeden. Den sekundzre s&e1 som den tertiaere struktur i dette kemeomrade er 
bevaret gennem hele serien af strukturer. Forskelle mellem struktnreme findes primazrt i de terminale 
dele af B-kaden. Sammenlignet med strukturen af B16 His mutanten, som denne struktur ligner mest 
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i serien af mutanter, bevirker indsattelsen af de ladede Glu sidekseder en ringere praecision af 
strukturen i begge B-kade terminaler. 
Maerkning af de to insulin mutanter (Bl, BlO, B16, B27) Glu, des-B30 og B16 His, des-B30 
med den NMR-aktive nitrogen-isotop ‘“N muliggsr bestemmelse af relaxationsparametrene, T, og Tz, 
samt NOE’en for ‘-‘N kerneme i backbone. Disse relaxationsparametre kan oversattes til en 
generaliseret ordens parameter, som er et udtryk for den rumlige begramsning af NH bindingens 
bevagelse pa pica-nanosekund tidsskalaen. For begge mutanter ses en fin korrelation mellem 
przcisionen af den beregnede strukturs backbone og dynamikken her. Terminalerne i B-kaden 
udviser stigende dynamik mod enderne, hvilket reflekteres direkte i faldende strukturel definition i de 
samme omrider. De to mutanters forskellige generelle strukturelle precision afspejles perfekt i deres 
overordnede dynamik niveauer. Endvidere observeres millisekund tidsskala dynamik i omrddet 
omkring svovlbroeme A7-B7 og A6-All ved neutral pH, dette tages som en indikation for isomeri 
omkring svovlbindingeme i broerne. Ved surt pH er dynamikken pa denne tiddskala spredt ud over 
samtlige sekundzre strukturelementer. 
A(I)-helix omridet er en de1 af et af insulins formodede receptor bindings-omrbder, muta- 
tioner i dette omrdde indvirker kraftigt pa den biologisk aktivitet. I fortsattelse af (Bl , Bl 0, B16, 
B27) Glu, des-B30 insulin mutanten er to mutanter med en ekstra mutation, A3 Gly hhv. A8 His, som 
giver 0.1 % hhv. 143 % biologisk aktivitet ii-emstillet. Begge mutanter er monomere under 
eksperimentelle betingelser svarende til basis mutantens. Den tre-dimensionelle struktur af de to 
mutanter er endnu ikke beregnet, men resultateme af de indledende NMR undersogelseme viser som 
ventet markante forskelle i A2-A8 omrbdet. For A8 His mutanten ses en klar stabilisering af helixen i 
omrbdet, herudover ses smi strukturelle azndringer i den de1 af B-kaeden, som ligger runligt tact herpa, 
isaer B9. For A3 Gly mutanten er alle tegn pa helix i A2-A8 omridet forsvundet, dette indvirker ikke 
kun pa strukturen i omrddet omkring B9, men ogsh pH strukturen i den C-terminale de1 af B-k=den og 
i nogen grad pA den centrale B-helix. 
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ABSTRACT 
Insulin circulates in the bloodstream and binds to its specific cell-surface receptor as a 5808 
Dalton monomeric species. However, shldies of the monomer stwchue and dynamics in 
solution are severely l imited by insulin self-association i to dimeo and and higher oligomers. In 
the present work we use site-directed mutagenesis of the dimer- and hexamer-forming surfaces 
to yield the first insulin species amenable for struchue determination at neutral pH by nuclear 
magnetic resonance (NMR) spectroscopy. The preferred insulin mutant, i.e., (Bl, BIO, Bl6, 
B27) Glu, des-B30 insulin retains 47% biological potency, and remains monomeric at 
mil l imolar concentrations in aqueous solution at pH 6.5-7.5 as judged by NMR and near-W’ 
circular dichmism (CD) spectmscopy. From a series of 2D ‘H-Nh4R spectra collected at pH 6.5 
and 34’C, the majority of the resonances are assigned to specific residues in the sequence, and 
nuclear Overhauser enhancement (NOE) cross-peaks are identified. NOE-derived distance 
restraints in conjunction with torsion restraints based on measured coupling constants, ‘JHNHa, 
are used for structure calculations using tbe hybrid method of distance geometry and simulated 
annealing. The calculated struchues show that the major part of the insulin mutant is structurally 
welldefmed with an average mot mean square (rms) deviation behveen the 25 calculated 
structures and tbe mean coordinates of 0.66 A for backbone amms (AZ-Al9 and 84-826) and 
1.31 A  for all backbone atoms. The A-chain consists of hvo antiparallel helices, A2-A7 and 
Al2-A19, connected by a loop. The B-chain contains a loop region (Bl-BS), an a-helix (B9- 
Bl9), a type I turn (B20-B23), and terminates as an extended strand @24-829). Ihe B  I-B4 and 
B27-B29 mgions are diswded in solution. The stn~cture is generally similar to crystal structures 
and resembles a crystalline T-stale more than a R-state in the sense that the B-chain helix is 
confined to residues B9-Bl9. 
FOOTNOTES 
‘Abbreviations: NMR, nuclear magnetic resonance; CD, circular dichroism; COSY, two- 
dimensional correlated spectroscopy; DQF, double quantum filtered; FID, free induction decay; 
NOE, nuclear Overhauser enhancement; NOESY, two-dimensional nuclear Overhauser 
enhanced spectroscopy; TOCSY, two-dimensional total correlation spectroscopy; nns, mot 
mean square. 
Insulin is central to the hormonal control of metabolism. Due to its importance as a 
pharmaceutical preparation for the treatment of diabetes mellitus, much effort has been directed 
towards understanding the stmchwl basis for insulin bioactivity. The protein is composed of 
two polypeptide chains, the A-chain (21 residues) and the B-chain (30 residues). Tl~e two chains 
are covalently lied by disultide bridges at A7-B7 and AZO-B19, and an intrachain disulfide 
bridge is joining A6 and Al I. The three-dimensional structure of insulin has been characterized 
in detail by X-ray analysis of aggregated species, notably zinc insulin hexamen (Adams et al., 
1969; Smith et al., 1984; Derewenda et al., 1989). The three principal hexamer conformations 
have been designated the Ts, TSR,, and %  forms, respectively (Kaarsholm et al., 1989). In each 
of these structures, the A-chain folds into a helix-loop-helix motif with helical stretches located 
in AZ-AS and Al2-Al9. The B-chain can assume hvo distinct conformations. In the T-state, the 
B-chain contains an extended N-terminal arm, central a-helix (B9-B19), type I turn (820.B23), 
and C-tetinal P-strand. In the R-state, residues Bl-B9 take up a helical conformation to form a 
region of a-helix contiguous from Bl-Bl9. The interconversion between the Te, T,R,, and %  
states of the insulin hexamer is modulated by a set of homotropic and heterotropic ligand 
biding interactions and has been shown to take place in solution (Kaarsholm et al., 1989; 
Braderet al., 1991; Bloom &al., 1995). 
Although insulin hexamers are extensively character&d by X-ray crystallography, the 
physiologically active form of tbe hormone is the 5808 Dalton monomer. Hence. in any 
diicussion of structure-activity relationships for insulin, it is necessary ta consider whether 
crystal packing forces have modified the stmchxe from that required for biological action. Due 
to the complicated pattern of insulin self-association i  solution, detailed NMR analysis of the 
3 4 
insulin monomer has often been ambiguous. Accordingly, several groups have reported results 
of NMR studies carried out at low pH (i.e., pH 1.8-3.5) using either modified insulins. organic 
co-solvents, or both, in an effort to counteract self-association (see e.g. Kline & Justice, 1990; 
Knegtel et al., 1991; Hue et al., 1991, 19929 1993b; Jorgensen et al., 1992; Ludvigsen et al., 
1994). The reported stmctwes generally agree that the secondary structure of the insulin 
monomer in solution is similar to that of the crystallographically identitied T-state. However, 
considerable differences are apparent in terms of the structural resolution expressed e.g. by the 
atomic l-m’ values. 
In one extreme, insulin stn~ctuxs with properties similar to a ‘molten-globule’ state 
have been reported. On the basis of these structures determined in the presence of 20% acetic 
acid, it ha been postulated that the lack of tertiary structural detail is intrinsic to the native 
insulin monomer and that the phenomenon per se is important for the interactions of insulin with 
its receptor (Hue et al., 1991, 19923, 1993a,b). In contrast wiiih these low resolution stmctures, 
our NMR studies on the biologically active B16 Tyr + His mutant in water at low pH have 
revealed a welldefined solution stmchue (Ludvigsen et al., 1994; Kaarsholm & Ludvigsen, 
1995). Because the B16 His mutant remains essentially monomeric at mill imolar concentrations 
in aqueous solution at low pH, these results identify sample homogeneity and aggregation state 
as major determinants for the quality of the NMR-derived structure. 
The high resolution solution structure of the insulin monomer at low pH provides an 
important prerequisite for the understanding of the interaction between insulin and its receptor. 
However, a long-term goal for these NMR studies is to determine the stmcturc and dynamics of 
5 
MATERIALS AND METHODS 
Materials. Native and mutant insulins were constructed by oligonucleotide-directed 
mutagenesis, fermented in yeast, and purified as described (Markussen et al., 1987; Brange et 
al., 1988). In a typical small-scale preparation, the mutant is expressed and partly purified as a 
single-chain mini-proinsulin precursor, B1..B29Lys-Ala-Ala-Lys-AlCily..A2l. Prior to the final 
purification step, the connecting peptide is cleaved off by treatment with a lysyl endopeptidase 
(Achromobacter Protease I, EC 3.4.21.50; Wake Inc., Japan), end the mutant insulin is isolated 
in the form of da-B30 Thr insulin. The removal of the B30 Thr residue has no effect on the 
biological potency of the molecule. 
CD Specrro~copy. CD spectra were recorded with a Jobin Yvon Mark V dicbmgraph 
calibrated with (+)-lo-camphorsulfonic acid as described (Kaasholm et al., 1993). Near-W CD 
spectra were recorded between 250 and 350 nm using an appropriate combination of cell 
pathlength and protein concentration to yield an absorbancy of less than 1. Protein 
concentrations were determined by W  absorbance using eas= 6.2 x 10’ M’cm-‘. The same 
extinction coefficient was used for estimation of the concentration of mutant species uith the 
assumption that each of the four tyrosines in human insulin contributes 25% to E~,~. 
NMR Specfroscopy. Samples were prepared by dissolving the lyophilized protein 
powder in IO/90 DzO/Hp or 99.8 %  40 and adjusting the pH as desired by additions of small 
amounts of 1 M  DC1 or NaOD. All pH meter readings are without correction for isotope effects. 
For all NMR experiments reported herein a temperature of 307 K was used. 
7 
engineered monomers under physiologically conditions as a base line for further structural 
examination of mutations associated with enhanced or dished affinity for the insulin 
receptor. 
Detailed NMR studies of the insulin mcummer at neutral pH have so far been limited by 
protein solubility and self-assofiation in addition to the inherently fester rate of NH exchange in 
this pH region. In the present work we use site-directed mutagenesis to manipulate the solubility 
end aggregation panem of insulin in the neutral pH region. These experiments identify a mutant 
and a set of conditions where the monomer is amenable for high resolution NMR structural 
analysis. The preferred mutant has glutamate residues substituted into four positions, i.e., Bl 
. 
Phe, BlO His, 816 Tyr, and B27 ti and the C-terminal 830 Thr is removed. This mutant 
retains 47% biological potency and is monomeric at mill imolar concentrations in the pH range 
6.5-7.5. The resulting structure is generally well-defined as evidenced by a high number of 
sequential NOES as well as many long range NOES. Apparent disorder is observed near the 
termini of the B-chain, e.g. Bl-B4 and B27-B29, and is to a large extent ascribed to local effects 
of the mutations. 
Two dimensional ‘H-‘H NMR spectrq DQF-COSY (T’iantini et al., 1982; Rance et al., 
1983). NOESY (Jeener et al., 1979; Anil-Kumar et al., 1980, 1981) and TOCSY. 
(Braunschweiler & Ernst, 1983; Bax & Davis, 1985) were recorded on a Bmker AMX600 
spectrometer. For TOCSY and NOESY spectra, mixing times were between 40.90 end 120-l 80 
ms, respectively. All spectra had a spectral width in both dimensions of 6579 Hz, 1024 tl 
increments were acquired each with a size of 2048 real datapoints. The spectra were recorded in 
the phare-sensitive mode using the time proportional phase increment&m scheme (TPPI, 
Marion & Wiithrich, 1983). The carrier was placed on the water resonance to enable inidation of 
the wter during a period of 1.5 s behveen the individual scans. 
Prior to Fourier transformation the FID’s were zero filled once in both dimensions. For 
resolution enhancement of the DQF-COSY spectra, a squared sine-bell shifted 90° was used in 
both dimensions. whereas for the NOESY and TOCSY spectra, a Gaussian function v&h an 
exponential line broadening of -7 Hz and a factor of 0.15 was applied, Data processing was 
performed using the MNMR package (PRONTO Software Development end Distribution, 
Copenhagen, Denmark) or the Bmker UXNMR software on a Silicon Graphics Indigo 
computer. Exchange of amide protons was followed by a series of SK datapoint one-dimensional 
spectra. These spectra were zero filled once, and a 1.5 Hz line broadening was used as a window 
multiplication prior to the Fourier transformation. 
The program PRONTO (PRONTO sofhwe Development and Distrubution; see Kj;er 
et al., 199 1) was used to keep track of spectral assignments, cross-peak integration, sequence- 
0 
specific and stereo-specific assignments and related bookkeeping during spectral analysis. 
‘J,NHa coupling constants were measured by the facility in the PRONTO s&ware which uses a 
combined analysis of COSY and NOESY spectra (Ludvigsen et al., 1991). Chemical shifts were 
measured in parts per million as observed relative to dioxane (3.75 ppm). 
Slrucfwe Calculafions. The program X-PLOR (Brilnger, 1992) was used to calculate 
swchres based on distance- and dihedral angle restraints derived from the NMR spectra. 
Integrated NOESY cross peaks were divided into three classes of distance restraints using I .O A 
as lower limit and upper limits of 2.7, 3.3 and 5.5 A. respectively. For restraints involving 
methyl groups, an additional 0.5 A was added to the upper limit. The measured ‘JHNR coupling 
~mstants were converted into +-angle restraints as follows: -60% 30° (2-4 Hz); -7OO 4 30” (4-6 
Hz); -IZOo* 60 (6-8 Hz); and -120”i 35’(8-10 Hz). The stereospecific assignment of several p 
methylenc protons was obtained by combined analysis of COSY cross peak patterns (Hybert et 
al., 1987) and of the intrarcsidual NOE intensities between the methylene protons, the ct- and the 
amide protons, respectively (Wagner et al., 1987). This method allowed assignment of the side- 
chain to one of the three staggered conformations, xl, assuming the values -60D f 60”, 60’ + 60”, 
or 180’ i 60°. Stereospecific assignment of 8 methyl groups of Leu residues were found and 
converted to fi restraints in a similar fashion. The stmcturc calculations were performed using a 
combination of distance geometry (Crippen & Have]. 1988; Kuszewski et al., 1992) and 
simulated anncaliig as proposed by Nilges et cl. (1988). 
Comparison of solution structures. From the Protein Data Bank (PDB), Brookhaven 
(January 1996) all tiles containing stmctures of monomeric native and mutant insulins 
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RESULTS 
Design of Monomeric Insulin Suirable for ZD NMR (II Neufral pH The aggregation 
and precipitation paflcm of insulin is a complex function of protein concentration, pH, 
tempcratwc, metal ions, ionic strength, and solvent composition. In the millimolar concentration 
range usually required for high-resolution NMR structural work, metal-free insulin exists 
predominantly as dimers and higher oligomcrs at pH 2.0-3.5. At higher pH aggregation 
increases, which in turn leads to precipitation in the pH region between 4.2 and 6.6. Above pH 
6.6 insulin dissolves, presumably as a mixture of dimen and higher aggregates, which then 
gradually dissociate as the pH increases. As the pH is raised above 10-l I, the monomelic state is 
finally reached (Jeffrey & Coates, 1966; Pekar & Frank, 1972; Lord et al., 1973; Goldman & 
Carpenter, 1974; Jeffrey et al., 1976; Pocker & B&as, 1981; Straua et al., 1985; Mark et al., 
1987; Kaarsholmetal., 1990; Roy et al., 1990% Kadiia et al.. 1992). The X-ray stmchwc ofthe 
Ts zinc insulin hcxamer shows that distinct interfaces arc involved in insulin dimer and hexamer 
packing (Baker et al., 1988). The published equilibrium constants for solution aggregation 
along the monomer/monomer interface arc similar at pH 2 and pH 7 (i.e., zz 10’ M’). However, 
the corresponding aggregation along the diierldimer interface appears much stronger at pH 7 
than at pH 2 (Mark et al., 1987). Hence, in contrast with the situation at low pH (Ludvigsen et 
al., 1994), insulin self-association must be inhibited along two distinct interfaces in order to 
obtain monomers at mill imolar concentrations at neutral pH. At the same time, the resulting 
mutant should retain near-native biological potency and the solubility pattern must allow NMR 
mcasurcment in a pH range where the exchange rate of backbone NH is sufficiently slow for 
obsewation with conventional ‘H-NMR techniques (Wttthrich, 1986). 
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determined by NMR were collected. Each tile contains an ensemble of stmchxes as well as a 
representative struchrc. For the purpose of comparison of the different st~ctllrcs, geometric 
average structures were calculated from these ensembles of stmchues following the alignment 
procedures presented in the literature references as listed in the header of the files. In order to 
obtain a reasonable comparison, we have made one exception to this procedure and used both 
chains rather than just the B-chain helix in the alignment of the DF? structures. Table III gives 
a summary of the experimental conditions and details concerning the structural calculations as 
referenced in the PDB files and in the original publications. The program X-PLOR (Briinger, 
1992) was used to calculate the average sttuchwes. 
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Aggregation propaies of various insulin mutants were evaluated by near-UV circular 
dichmism (CD) and NMR resonance line widths. The near-W CD spcctnvn (350-250 nm) bf 
insulin reflects the environment of the tyrosine cbmmophore. The signal is very sensitive to 
aggregation and may be used to monitor the formation of dimer interface (Morris et al., 1968; 
Goldman 8~ Carpenter, 1974; Wood et al., 1975; Strickland & Mercola, 1976). NMR spectra arc 
sensitive to insulin self-association because longer rotational correlation times lead to line 
broadening and because dynamic equilibria between oligomeric states can lead to line 
broadening in the intermediate-exchange regime. 
Figure 1 shows the aromatic and amide proton resonances of the ID ‘H-NMR spectra 
for human insulin (panel A) and a series of mutants (panels B-F) at 1 mM protein in IO/90 
DzOiH,O, pH 7.5. Under these conditions, human insulin exists as a mixture of dimers and 
higher aggregates and the resulting spectrum is very poorly resolved. The X-ray stnxture of the 
T, insulin hexamer shows that dimer fomwion is dominated by a series of non-polar contacts 
contributed by B-chain residues, notably 812 Val and B16 Tyr in the central helix, and residues 
B23-828 in the extended chain. Panels (B-C) illustrate the effects of introducing charged 
residues at two different positions in the monomer/monomer interface. As show in Panel (B), 
the B27 lln + Glu mutation at the edge of the monomcrlmonomer interface effects little or no 
improvement in spectral resolution relative to human insulin. This mutation has a minor 
inhibitory effect on dimer formation &age et al., 1988); however, in the present study the 
modification is preferred due to its positive effect on tbe expression level in yeast and hence on 
the overall fermentation yield during small-scale mutant preparation. Introduction of charge into 
17. 
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the Bl6 Tyr position has previously been shown to provide an efficient means of inhibiting the 
formation of dimer interface at low pH (Ludvigsen et al., 1994; Kaarshobn & Ludvigsen, 1995). 
In accordance with this result, panel (C) shows that the B16 Tyr + Glu mutation strongly 
enhances the spectral resolution at pH 7.5. While the (Bl6. B27) Glu species is nearly 
monomeric at 1 mM protein, the exchange rate of several NH-protons is too fast for observaiion 
in 2D spectra At slightly lower pH, extensive line broadening is observed in concert with 
aggregation along the dimerldimer interface. Accordingly, tbe number of cross-peaks observed 
in 2D NOESY spectra of the (816. B27) Glu mutant is signiticantly smaller at pH 7.0 than at pH 
7.5 (data not shown). 
When the T6hexamer is assembled from dimers through the coordination of Zn” to the 
BlO His residues, both polar and non-polar residues are buried between the dimers. The packing 
is correspondingly much looser than in the monomer/monomer interface within each dimcr. A 
set of important contacts across the dimerdimer interface involves the N-terminal part of the B- 
chain. Of ptiicular interest is the Bl Phc residue, which fit into a pocket between the main A- 
chain and Al4 Tyr residue of its neighbor. Because the two Al4 Tyr arc also in contact across 
the dimer-dimer interface, a close aggregate involving four aromatic residues is formed (Baker 
et al., 1988). Comparison of panels (B) and (D) in Figure I shows that the Bl Phe --f Glu 
mutation leads ta somewhat improved resolution of the ID NMR spectrum. A slightly better 
improvement is obtained with the BlO His + Glu mutation positioned at the edge of the 
dimer/dimer interface, viz panel (E). 
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Assignment of Spin Sysfems. NMR spectra were assigned using the standard procedures 
outlined by Wtithrich (1986). The fmgerprint region of the DQF-COSY specbum is shown in 
the upper panel of Figure 3. Ihe chemical shifts arc dispersed and well-resolved as expected for 
a stmcturcd globular protein, and 37 of the 47 possible HNH” cross peaks are annotated in the 
plot. Among the remaining HNH” cross peaks, six were assigned using TOCSY spectra These 
are the resonances that are either close to the water line or unusually broad, i.e., AS, A9, A12, 
B5, B6, and B26. The linewidth of the CysAIl amide proton is unusually broad, but 
identification was possible in DQF-COSY spectra. Amide protons from residues A2, B6 and B9 
were not identified. Finally, for the side-chains of Glu and Gln residues, considerable overlap of 
cross peaks in the HO-H’ area was resolved using TOCSY spectra occasionally supported by 
NOESY. 
Sequential Assignment and Secondmy Snuclure. The sequential assignment was 
straightfonvard for most parts of the insulin mutant. Including the regions B9-B29, A9-Al2, 
and Al3-A21. The assignment of the stretch from A4 to A8 was complicated by overlapping 
HN and H” resonances; this is reflected in the lack of sequential NOES as well as NOES 
indicative of secondary structure in this region. In the N-terminus of the B-chain, the NOES 
arc sparse and the assignments here were made by exclusion as the very last part of the 
procedure. 
The first indications of the secondary structures come from inspection of the chemical 
shifts of the a-protons compared to the random coil values (Wishart & Sykes, 1992). These 
chemical shift differences shown in Figure 4 suggest helical strwtures charactctizcd by 
upiicld shifts of the a-protons in the second part of the A-chain (the A(II)-helix) and in the 
The BlOHis + Glu mutation also has the effect of increasing the biological potency of 
the insulin molecule 4-fold as determined by the ability to incorporate [2-‘HI-glucose in isolated 
mouse adipocytes according to Moody et al. (19745. In the same assay, the B27 Glu, (Bl, B27) 
Glu, (B16, B27) Glu and des-B30 insulins exhibit potencies of 1.07, 0.97. 0.13 and 1.00, 
respectively, relative to a value of 1.00 found for human insulin. For the mutant carrying all 
modifications. i.e. (Bl, BIO, B16, B27) Glu, des-B30 insulin, a relative potency of 0.47 is found 
indicating that the substitutions affect the biological activity in a nearly independent manner. 
Panel (F) in Figure I shows that the ID spectrum of (Bl, BlO, Bl6, B27) Glu, des-B30 insulin 
is well-resolved and retains the dispersion of resonance lines characteristic for globular proteins. 
Furlhemmre, as the pH is adjusted down to 7.0-6.5, the high resolution is maintained (panels (G) 
and (H)), while selected NH resonances become sharper as expected due to the slowed exchange 
rate. 
Figure 2 shows near-m CD spectra as a function of protein concentration for native 
insulin at pH 8.0 and the (B I, BlO. Bl6,827) Glu, dcs-B30 mutant at pH 6.5 and 7.5. For native 
insulin, the progressive increase in intensity of the negative signal around 274 nm indicates the 
expected increase in association with increasing concentration. In contrast, the near-W CD 
spectrum of the mutant is independent of the protein concentration in the 60 pM to 2.6 mM 
range at both pH 6.5 and 7.5. Although the mutant is missing one tyrosine reporter group (Bl6). 
Tyr B26 is expected to be strongly affected by monomer/monomer interactions. Hence, these 
results provide further evidence that the (BI, BlO, B16, B27) Glu, des-B30 mutant is 
monomeric under conditions necessary for NMR structural studies at neutral pH, and this 
species was selected for detailed charactcrization. 
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central part of the B-chain (the B-helix), whereas the helix expected in the N-terminus of the 
A-chain (the A(I)-helix) seems less well defined. These observations arc substantiated by the 
NOES assigned in the same regions as shown in Figure 5 and in the NOE matrix in the lower 
panel of Figure 6. The B-helix, stretching from B9 to Bl9, is a well defined helix 
characterized by a dense nehvork of NOEs between the a-protons in position i and the amide 
protons in position i+3 and position i+4 as well as the P-protons in position i+3. Furthermore, 
stronger NOES between amide protons 2 residues apart in the helix are found. The C-terminal 
A(II)-helix comprising the amino acids from Al3 to A20 has a less dense nchvork of NOES, 
i.e., only between a-protons in position i and p- and amide protons in position i+3. The N- 
terminal A(I)-helix stretches from A2 to A6 and is characterized by the same type of NOES as 
the A(lI)-helix. In the lower panel of Figure 3, the HN to HN part of the NOESY spectrum is 
shown with annotations for the sequential assignment of the helical areas. 
An amide proton charactcrized by an exchange rate slower than the average is a good 
evidence for participation in a hydrogen bond either in a secondary structural clement or as 
part of the tertiary fold of the protein. At near neutral pH, the exchange rate of amide protons 
is in the order of IO’ mid’ (Englander et al., 1972). From ID proton spectra recorded in the 
period between I2 and 60 minutes after dissolution of the insulin mutant in D,O, it is possible 
by visual inspection to follow the decay of amide proton resonances belonging to the B-helix 
and the A(U)-helix Y well as a single amide proton in the A(I)-he&x. After 50 minutes, all 
amide protons are exchanged by deuterons. The locations of the slow exchanging amide 
protons according to this criterion are shown in Figure 5. 
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Slruc~ure Cdculdons. Table II lists the number of distance restraints and dihedral 
angle restraints used for the find stmchxe calculations. In addition, the sultide bridges wem 
added as distance restraints, while no restraints were added for hydrogen bonds. The matrix in 
the lower panel of Figure 4 shows the distribution of NOES between residues. Multiple 
occurenccs of NOES from both sides of the diagonal in a spectrum or from different spectra 
were filtered out before the conversion of NOES to distance restraints. As a supplement, the 
. 
upper panel of the same Figure depicts the number of NOES by residue. The distribution of 
dihedral angle restraints on residues is shoun in Figure 5. The calculation of structures using 
X-PLOR 3.0 proceeded as described in Materials and Methods starting from a reduced set of 
distance restraints. In a sequence of iterations, this set was slowly expanded as ambiguities 
could be resolved, and finally the dihedral angle restraints wcrc introduced. A total of 100 
stmctmcs were calculated 25 of which were characterized by distance restraints violations 
below 0.3 A, dihedral angle restraints violations below 2’, and a low total energy. Table II 
summtizes the structural statistics for this set ofstructures. 
The set of 25 converged st~ctures is depicted in Figure 7 (backbone representation) 
together with their geometric average represented by a ribbon. In Figure 8, the side-chains 
have been included, and the average structure shown here is c&red according to the atomic 
tms deviation. 
Description offhe S~rucfures. The major part of the mutant sttuc1urc is well-defined. 
This goes indeed for the B-helix (BS-Bl9) which exhibits low rms deviation among the 
strwtwcs as expected from the large number of structural NOES as well as the small coupling 
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DISCUSSION 
Tote (Bl, BlO, 816, B27) Glu, des-B30 mutant is the first example of an insulin species 
that remains monomeric at mill imolar concentration in aqueous solution at neutral PH. Hence, 
by tailored mutations in hvo dinstict protein/protein interfxes, the inherent self-association of 
insulin is strongly inhibited, while the biological potency is essentially retained. As a result, 
samples may be prepared under conditions where the exchange rate of backbone amide protons 
is sufficiently slow for detailed NMR analysis. Previous NMR invesligations of native and 
mutant insulins at near-neutral pH have been limited by incomplete assignments of the spectra. 
Nevertheless. on the basis of ID spectra of human insulin at high dilution and of the B9Ser + 
Asp monomeric mutant in the pH X-Y.5 range, Roy et al. (199Oa,b) were able to show that the 
association of insulin monomers into dimers is accompanied by a change in conformation 
involving the relative position of residues BIS Leu and B24 Phe. In their NMR analysis of the 
BIO Asp, B28 Lys, B29 Pm (DKP) insulin monomer al pH 8.0, Weiss et al. (1991) also reported 
partial assignments and employed selective k and “C labeling of the B23-B26 residues to 
co&m that this region is indeed in close contact with residues from the central B-chain helix. 
The (Bl, BIO, B16, B27) Glu, des-B30 mutant is stmchtmlly well-ordered with the 
exception of the B-chain termini, i.e., residues Bl-B4 and B27-B29. The observed disorder in 
the N-terminus is most reasonably ascribed to opposing effects of the Bl and BIO mutations. 
Removal of the hydrophobic Bl Phe side-chain destabilizes the packing of the Bl residue 
against the Al3 Leu region (Ludvigsen et al., 1994). while the BIO Asp side-chain caps the 
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constants, indicative of helix structure. The hydrogen bonds tit a regular a-helix pattern all the 
way starting from B9(CO)B13(HN) and ending at the last donor B19(HN). 
At the C-terminal end of the helix, a type I turn from B20 to B23 tmns into a p strand 
that stretches along the central helix. The three C-terminal residues ae disordered. As is 
evident from Figure 4, no NOE structural information was obtained in the Bl-B4 region of the 
B-chain. This fact is reflected in the random distribution of the termini among the 25 
structures presented in Figure 7 and implies that the average structure calculated in this area is 
physically meaningless. The A(U)-helix (Al3-A20) shows a high degree of accordance within 
the bundle of sttwttues, and the hydrogen bonding pattern tits an a-helix 
A13(CO)A17(HN). AIS(*A19(HN), and A16(CO)A20(HN), starting out with the 
irregular Al2(CO)-AIS hydrogen bond. The A(l) helix (AZ-AS) is a little less well- 
defined. a single hydrogen bond between A2(CO) and A6(HN) is established. The loop area 
(A9-A12) connecting the two A-chain helices shows a larger spread of confmmations. In 20 
cm1 of 25 calculated structures the interchain hydrogen bond A19(CO)B25(HN) is 
established, in agreement with crystal structwcs. The atomic rms deviations calculated are 
presented in Table II along with the general structural statistics. 
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central B9-Bl9 helix and hence stabilizes the T-state relative to the R-state (KCaarsholm et al., 
1993). In any event, because the B-chain helix is clearly cotuiied to residues B9-B19, the 
ovemIl stmchue resembles a ctystallogmphic T-state more than a R-s!&. In the C-terminal 
B29-B30 residues, disorder is observed in the crystal st~ctmc as well as in the IowpH solution 
stmchre (Baker et al., 1988; Ludvigsen et al., 1994). In the present work at neutral pH, the lack 
of stmchtml detinition extents to the last three residues, B27-B29. Again, the effect is most 
likely due to the modifications employed, i.e.. the introduction of negative charge close to the 
shortened C-terminus ( B27 Thr + Glu , des-B30). In accordance with previous work (Kline & 
Justice, 1990; Ludvigsen et al., 1994). broad amide proton resonances are observed in the A- 
chain loop region suggesting that conformational substates exchange on a mill isecond time scale 
in this particular region. 
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Comparison W W  Olher Monomer Solution Srrucmres. Several NMR investigations of 
insulin monomers have been carried out at low pH and/or in the presence of organic co-solvent. 
Table III compares experimental conditions and details conccming the structure calculations for 
the (Bl, BlO, B16, B27) Glu, des-B30 mutant and for other insulin monomer stmchues 
deposited in the Bmokbaven Data Bank. In addition to these monomers, the stmchue of a 
B9Asp insulin dimer has been described (Jargensen et al., 1992), and the low-pH structure of 
DPI has been determined by Knegtel et al. (1991) as well as by Hua et al. (1992a). Figure 9 
compares the three dimensional structure of (BI, BIO, B16, B27) Glu, des-B30 insulin with 
those of the other monomers. The stmchxes are color coded according 10 the atomic rms 
deviations chamctcrizing each of these ensemble average stmctwes. Table III contains details 
concerning the average structllre calculations, alignment procedures and rms deviations of the 
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backbone calculated by using the same alignment procedure for all mutants. Note that for certain 
parts of these stmchtres, distance restraints containing information about second.uy and let&y 
fold are either absent or very few in number. This is particularly true for the C-terminal B22- 
B30 residues of the B24 Gly and B24 Ser mutants (Hua et al., 1991, 1993b). As a result, 
considerable atomic rms deviations are obtained which make the average structures physically 
meaningless in these parts c&red red in Figure 9. Paradoxically, a distinct bulge appears on the 
C-terminal P-strand of the B24 Ser structure. 
The precision of the individual struchxes is quantified by the ensemble average rms 
deviations in Table 111. A comparison of the two column of backbone rms deviations in the 
Table reveals that most of the differences are caused by imprecision of the C-terminal of the B- 
chain. The B16 His stmchuc shows the highest degree of overall accordance behwen the 
individual struchtres in the ensemble. In this case, the prcsicion is directly correlated with the 
number of interresidual distance restraints used in the structure calculation. However, due to 
differences in the procedures for counting of the NOFs and for the translation of NOE’s into 
distance restraints, the correlation between structural precision and the number of NOE’s is 
generally not straightforward. The high precision of side-chain struchues in Bl6 His insulin arc 
closely related to the number of stereospecific assignments of y.t and 2 dihedral angles. The 
individual monomer svuctur~s are compared one by one in Table IV. It is clear that the 816 His 
insulin has the closest stmchuaI resemblance to the (Bl, BIO, B16, 827) Glu, des-B30 mutant. 
Tbe major difference behvcen these two SWC~~~S is the lack ofdefinition of residues Bl-B4 in 
(Bl, BIO, B16, B27) Ght, dcs-B30 insulin. In B16 His insulin, the close contact between B- 
chain N-terminus and the A-chain loop region provides the set of NO& detining the spatial 
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of the molecule where the number of restraints per residue is well below tbe average, i.e.. the 
outermost parts of both chains. Tbe same procedure was used by Knegtel et al. (1991) for the 
alignment of DPL With this pmcedhe, the major part of all molecules (including DPI) exhibit 
reasonably well-ordered secondary and tertiary stmchtrc. For the (Bl, BIO, Bl6, B27) Glu, des- 
B30 mutant at neutral pH and the Bl6 His mutant at low pH. the dispersion of side-chain 
rescmances comesponds to that expected for a packed, globular protein. Furthermore, both 
mutants exhibit a distinct near-UV CD specttum very similar to that of native human insulin 
(Figure 2 and Ludvigsen et al., 1994). Hence, there seems to be no evidence coming from NMR 
or CD to support the idea that insulin mutants exist in a molten globule state characterized by 
variations in the mutual arrangement of the chains. 
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arrangement of the loop. Thus, the lack of stmchtr~ in residues BI-B4 propagates to an 
increased inpresicion of the A-chain loop region in (Bl. BIO, B16, B27) Gltt, da-B30 insulin. 
Finally, we note that with the exception of the B-chain termini, the stmchxes depicted 
in Figure 9 share cmnmon features including the seconday stmctmc elements and tbc overall 
spatial arrangement of these elements into the tertiary stmctwe. Ai would be expected for a 
globular protein, Table III shows that each struchu-al core is characterizcd by a low rms 
deviation (high precision) relative to the precision of the overall structure. In contrast with these 
calculations, Hua et al. (19924 I993a) reported that variations in the mutual spatial anangement 
of the hvo chains in the case of DPI span the differences reported among various insulin crystal 
forms. The phenomenon ws ascribed to the absence of restraints and interpreted as evidence 
that DPI exists in a ‘molten globule’ state under native-like conditions (Hua et al., 1992a, 1993a). 
A molten globule state is usually chamctetized as a compact denatured state arising as an 
intermediate in the pathway from native to unfolded protein under slightly denaturing conditions 
(see e.g. reviews by Dobson (1992,1993)). The state is character&d by the presence of 
secondary stmchtral domains, but absence of tertiary interactions, i.e., the conformation of the 
side-chains is essentially random. In a NMR spectrum, one feature of a molten globule state 
would be a reduced dispersion of side-chain resonances in comparison with the native state 
(Goto & Fink, 1989). The original alignment of the DPI ensemble presented by Hua et al. 
(1992a) was based cm a subset ofthe swchue, i.e., the central B-chain helix (residues B9-Bl9). 
This procedure per se leads to an accumulation of the overall structural imprecision in the parts 
that arc I& out of the alignment, in this case the entire A-chain and the B-chain letmini. In 
contrast, our alignment procedure (Table III) is based on both chains leaving out only those parts 
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Table II Structural Statistics 
Table 1 ‘H chemical *lifts oftbe insulin mutant at pH 6.5 and 307 K mcasurcd in ppm relative 10 dioxanne 
(3.75 pptg 
inharesidual 297 
rhon range 193 
long range 51 
crms chain 56 
. 
p 
Total enmgy 43.8 r 3.8 
Bonds 2.2 * 02 
A”& 25.5 * 2.2 
Repel 7.4 * 1.2 
NO&’ 4.1 * 1.3 
TOG¶” 0.3 * 0.1 
hnpropcrr 3.3 * 1.3 
1.23 
2.03 
2.23,2., I 
2.22 
2.9813.37 
3.820.38 
4.49 
4.09.3.95 
1.70 
3.43”.14 
4.05,4.19 
1.60,,.7J 
3.1113.13 
2.37,2.16 
I.Jlt2.07 
2.11 
2.65.2.71 
3552.89 
2.90.3.43 
2.8x2.75 
2.17 
2.87i2.84 
2.00r2.20 
3.261357 
l.OW.76 
3.05;3.27 
4.0914.03 
2.32.2.16 
1.89.124 
2.18 
2.10 
1.49 
0.28.1.09 
2.321269 
1.89.1.77 
2.09 
3.01.3.40 
2.17 
2.1m.29 
3.42.3.02 
3.250.32 
3.o6/3.oo 
2. IO,, 94 
2.25 
1.77.1.90 
y, 1.2210.95 y> 0.77 & 0.60 
y1 0.97 yz 1.03 
y 255R.33 
9 2.488256 y 7.om.52 
4 1.320 
q, 1.29,o.n I$* 0.78 H6 0.66 
H, 1.76 H,, I.00 H. 0.91 
H, 7.23 H. 6.96 
y 2.4*m2 y 6.857.45 
H, 1.85 Ha0.8010.84 
H, 2.38~2.45 
H* 7.24h5.68 
Ha 7.3 H. 6.87 
“4 6.437.49 
y 1.0111.04 
HI 6.89n.59 
H, 2.34 H, 7.49~5.9, 
Ha 724 “., 8.29 
H, 1.64 Ha, 0.*5/0.9, 
y 2ASR.52 
H, 1.32 H,o.,6 
y, 1.04 H,2 1.09 
y 2.51R.3, 
H, 1.33 HII 0.35 H, 0.66 
y2.4,rz.n 
Hs, 0.99 H,, 0.74 
y, 1.12y,o.97 
~2.2v2.45 
H, 1.97 Ha 3.49D.43 H. 7.35 
Ha 6.90 H. 7.28 HL 7.3 
HI 7.37 H. 7.44 
H, 7.0, H. 6.74 
y2.30 
H,, 2.03 H+ 2.12 Ha, 3.79 Ha> 3.63 
y 1.0011.46 & 1.74 y 3.02 
A2 !I; 5.9, 
A3 “a, 8.24 3.66 
A4 G,” 8.34 4.21 
AS Gh 8.18 4.15 
A6 
A7 
A8 
A9 
AI0 
All 
A12 
A,3 
Al4 
AI5 
A16 
A,, 
A,8 
Al9 
A20 
A21 
B, 
82 
83 
cvr 8.33 4.96 
8.32 4.91 
8.18 4.20 
7.43 4.80 
7.85 4.3, 
9.53 5.08 
8.36 4.7, 
9.05 4.08 
7.8, 4.44 
7.58 4.12 
7.88 4.18 
7.91 4.52 
7.44 4.5, 
I.?” 
Glu 
8.05 4.42 
7.33 5.29 
8.08 4.58 AStl 
Gl” 
VC4 
Am 
Ghl 
His 
Leu 
CYS 
GIY 
SW 
CR” 
k” 
“al 
GlU 
Ala 
Lcu 
CA” 
lx” 
“al 
CYS 
G,Y 
Cl” 
4.19 
4.82 
4.54 
4.71 
4.6, 
5.00 
4.28 
4.23 
4.19 
4.02 
3.3 I 
4.07 
4.19 
3.76 
4.23 
4.23 
3.85 
4.92 
4.,1,4.09 
4.2, 
4.23 
3.9414.23 
5.36 
4.96 
4.72 
4.77 
4.37 
4.24 
8.6, 
8.09 
8.42 
8.81 
8.61 
8.13 
Bond (A) 0.001, * 0.0001 
Angle (de*) 0.35 * 0.02 
Improper (dcg) 0.26 f 0.04 
NOE (A) 0.012 * 0.002 
Torsion (A) 0.29 * 0.05 
I34 
8.5 
86 
8, 
88 
l39 
B,O 
B,, 
BIZ 
B,, 
814 
81.5 
816 
81, 
r318 
819 
820 
B2I 
8.2, 
7.1 I 
7.13 
7.9, 
0.0-0.1 A 31.8 * 3.1 
0.1-0.2 A 2.0 * 1.0 
0.2-0.3 A 0.16 * 0.37 
20.3A o 7.56 
8.03 
8.29 
7.6, 
8.38 
8.8, 
7.87 backbonc(all) 1.31 * 0.19 
heavy atoms(a,,) 1.88 * 0.23 
backbone(A2.A19)’ 0.6, * 0.13 
backbonc(B4-826)’ 0.64 * 0.09 
backbone(A2-Al9,B4-B26)’ 0.66 * 0.09 
9.19 
8.14 
7.36 
7.6, 
8.65 
B22 
B23 
B24 
B2S 
826 
B27 
828 
829 
Phe 
Phe 
TY 
Gl” 
8.0, 
7.84 
7.82 
’ Force constants for distance and torsion angle restraints are 50 kca, mol” X2 and 200 kca, m&’ 
radiad’ 
bCHARMM potential (Bmokr et a,., 1983) used for van der Waa, energy cahulation 
‘Ali*nmentafA2-AID and 84-826 backbone 
30 
Table IV Comparison of solution structies of human insulin and mutants”. 
‘The mot mean square deviations of the backbone were determined aligning the regions AZ-AI9. 84. 
B19 above the diagonal and the helix regions AZ-A*. A13-A19. B9-B,9 below the diagonal. ?IE 
~tnmures are ensemble averages aligned as listed in Table 11,. 
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Figure Legends 
Figure 5 Summary of the data used for sequential assignment and determination of 
secondary structural elements. The thickness of the bars indicates the intensity of the NOES as 
measured in a NOESY spectrum with a mixing-time of 150 ms. The coupling constants and 
the x, dihedral angles were measured as d&bed in Materials and Methods. The filled circles 
indicate that the amide proton signal is observable in a 1D spectrum at least 12 minutes after 
dissolution of the sample in D,O. 
Figure 1 1D NMR spectra showing the aromatic and amide proton resonances of native and 
mutant insuims at 1 mM protein concentration in IO/90 DzO/HzO, 307 K. Panels (A): human 
insuli pH 7.5; (B): 827 llu + Glu , pH 7.5; (C): (T316, B27) Glu, pH 7.5; (D): (Bl, B27) Glu, 
pH 7.5; (E): BlO Glu, des-B30, pH 7.5; (F)-(H): (Bl, BIO, Bl6, B27) Glu, des-B30 insulin at 
pH 7.5,7.0 and 6.5, respectively. 
Figure 2 Near-W CD spectra as a function of protein concentration. (A): zinc-free human 
insulin in 10 mM Tri+.ZlO;, pH 8.0, and C.-k) 5 pM, (---) 20 pM. (-. $200 pM, and (-) 2 
mM protein. (B) and (C): (Bl, BlO, 916. B27) Glu, dwB30 mutant insulin in 25 mM 
Tris/CIO,‘, pH 7.5 (B) and 25 mM phosphate, pH 6.5 (C), and +) 50 PM, (-. $ 600 pM and 
(--) 2.6 MM protein. 
Figure 3 Sections from the DQF COSY spectrum (top) and NOESY spectrum (mixing-time 
180 ms) (bottom). The fingerprint region of the DQF COSY spectrum shows the major part of 
the correlations between a-protons and amide protons that was identified. The correlations 
between amide protons indicative of helical areas in the stmctum are annotated in the bottom 
panel, and lines are drawn to follow the amide protons throughout the helices. 
Figure 4 Difference between chemical shifts of the a-protons and the random coil values 
(Wishart et al., 1992). Stretches where the secondary chemical shifts indicate an a-helix are 
marked. 
Figure 9 Ensemble averages of three dimensional structures of native (HI) and mutant 
insulins determined by NhR The structures are color coded according to the atomic mot 
mean square deviation of the backbone. For further details, see Table III. 
Figure 6 Panel A shows the distribution of NOES by residue, i&residual NOES are marked 
with filled boxes and interresidual NOES with vertical lines. In the matrix in panel B tilled 
circles indicate the presence of at least one NOE between the connected residues. Multiple 
occurences of NOEs on both sides of the diagonal in a spectrum or in different spectra were 
filtered out before the conversion to distance restraints. The presence of helical regions, as 
expected from the panems of NOES, is indicated. 
Figure 7 The backbone of 25 converged stmcturcs of the insulin mutant superimposed 
together with their geometric average. The average structure is represented by a ribbon, the A- 
chain is shown in red, the B-chain in blue. The stmctwes are aligned in the regions B4-B26, 
AZ-A19. 
Figure 8 The geometric average structure of the insulin mutant c&red according to atomic 
mu. The average structure was calculated based on alignment of residues 94-926 and A2- 
A19. 
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resonances become sharper as expected due to the 
slowed exchange rate. 
Figure 2.4 shows near-UV CD spectra as a 
function of protein concentration for native insulin at 
pH 8.0 and the (Bl, BlO, B16, B27) Glu, des-B30 
mutant at pH 6.5 and 7.5. For native insulin, the 
progressive increase in intensity of the negative signal 
around 274 run indicates the expected increase in 
association with increasing concentration. In contrast, 
the near-W CD spectrum of the mutant is 
independent of the protein concentration in the 60 uM 
to 2.6 mM range at both pH 6.5 and 7.5. Although the 
mutant is missing one tyrosine reporter group (B16), 
Tyr B26 is expected to be strongly at&&d by 
monomer/monomer interactions. Hence, these results 
provide further evidence that the (Bl, BlO, B16, B27) 
Glu, des-B30 mutant is monomeric under conditions 
necessary for NMR structural studies at neutral pH 
and this species was selected for detailed 
character&&on. 
2.4.2 Assignment of Spin Systems 
NMEC spectra were assigned using the 
standard procedures outlined by Wfithrich (1986). The 
fingerprint region of the DQF-COSY spectrum is 
shown in the upper panel of Figure 2.5. The chemical 
shifts are dispersed and well-resolved as expected for a 
structured globular protein, and 37 of the 47 possible 
HNP cross peaks are annotated in the plot. Among 
the remaining H%? cross peaks, six were assigned 
using TOCSY spectra. These are the resonances that 
are either close to the water line or unusually broad 
i.e., A8, A9, A12, B5, B6, and B26. The linewidth of 
the CysAll amide proton is unusually broad, but 
identification was possible in DQF-COSY spectra. 
Amide protons from residues A2, B6 and B9 were not 
Insulin Structure 
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Figure 2.5 Sections tiom the DQF COSY spectrun 
top) and NOESY spectrum (mixing-time 180 ms: 
lbottom). The fingerprint region of the DQF COSE 
spectrum shows the major part of the correlationr 
Jetween a-protons and amide protons that wa: 
Identified. The correlations between amide proton: 
ndicative of helical areas in the structure art 
nmotated in the bottom panel, and lines are drawt 
;o follow the amide protons throughout the helices. 
1 
identified. Finally, for the sidechains of Glu and Gln 
residues, considerable overlap of cross peaks in the 
H?-l-P’ area was resolved using TOCSY spectra 
occasionally supported by NOESY. 
17 
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Figure 4.2 Sections from DQF-COSY spectra (top) and NOESY spectra (mixingtime 120 ms 
bottom). In the fingerprint region of the DQF COSY spectrum the major part of the identifiec 
:orrelations between a-protons and amide protons is annotated. The correlations between amid1 
protons of neighboring residues, indicative of helical areas in the structure, are annotated in the botton 
panel and lines are drawn to follow the amide protons throughout the helices. 
Part of the secondary structural eIements 
of the mutants, the helix regions, are indicated in 
the excerpts from the NOESY spectra in the 
bottom panel of Figure 4.2. Intense HNHN 
connectivities are assigned for both mutants in the 
B-chain helix region, BlO-B20, and in the A(II)- 
helix region, A14-A20. In contrast to the +A3 Gly 
mutant (and the basis, Figure 2.4), the spectrum of 
the +A8 His mutant shows intense HNHN 
connectivities in the A(I)-helix, A3-A7. This is an 
evidence of the helix stabilization caused by the A8 
Thr + His mutation in the helix C cap. Note that 
the basis mutant spectra do show HNHN con- 
nectivities in the A3-A5 region, these peaks are 
less intense and visible, but not annotated, in 
Figure 2.5. 
Further indications of secondary structure 
come from comparison of the a-proton chemical 
shift and the random coil values, the secondary 
chemical shifts of the ix-protons. Data for all three 
mutants is shown in the left-hand column of Figure 
4.3. The helix elements predicted by the extents of 
51 
